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Abstract: 
Peroxisomes are organelles which are vital for human health and development. 
They represent dynamic subcellular compartments which play cooperative roles 
in essential cellular metabolic processes such as lipid metabolism and redox 
balance. For example, cooperation between peroxisomes and the endoplasmic 
reticulum (ER) is essential for the production of myelin lipids which are required 
for normal neurological function. We recently discovered that peroxisome-ER 
interaction is mediated by physical linkages in the form of membrane contact 
sites. These contact sites are mediated by the interaction of peroxisomal 
ACBD5 and ER-resident VAPB proteins. ACBD5-deficient patients have 
recently been identified who display retinal dystrophy, white matter disease and 
accumulation of very-long-chain fatty acids, which can only be degraded in 
peroxisomes. There is currently a need to develop simple and robust tools to 
allow efficient visualisation and quantification of these membrane contact sites 
to further their characterisation and investigate their function. Moreover, these 
should allow the dynamics of membrane contact sites under physiological 
conditions to be assessed. This study presents the optimisation of two systems 
to investigate peroxisome-ER interactions, the proximity ligation assay, 
Duolink® and a split fluorescent reporter system, split superfolder green 
fluorescent protein. These allow peroxisome-ER interactions to be visualised 
and measured in situ with a fluorescence-based readout when the organelles 
are in close proximity. These systems are powerful and modifiable and will help 
further characterise peroxisome-ER (or other organelle) membrane contacts 
and shed light on the interplay between peroxisomes and the ER. 
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Chapter 1: General 
Introduction 
The role of peroxisomes in health and disease and their 
cooperation with other subcellular compartments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
Eukaryotic cells are defined by their highly organised internal architecture. This 
is composed of a set of membrane-bound subcellular structures, known as 
organelles, which each play specialised roles. Organelles allow for normal 
functioning of the biological system through providing spatial and temporal 
separation of incompatible metabolic processes, allowing them to occur 
simultaneously. The interest in organelles and the roles they play continues to 
increase as new biological functions and molecular features are identified, 
revealing the role of these structures in both health and disease (Satori et al., 
2013). Moreover, recent studies have led to the understanding that organelles 
do not function exclusively as separate entities as once thought, rather they 
cooperate extensively, forming a so-called organelle interactome (Valm et al., 
2017). 
The first observation of organelles was in 1682 by microscopist Antonie Van 
Leeuwenhoek who noted the presence of a nucleus in the red blood cells of fish 
species (Harris, 2000). However, the significance of this finding was not realised 
until 1833, when botanist Robert Brown rediscovered this structure and coined 
the term “nucleus”. This then resulted in the observation of this structure in 
many cell types before its function was uncovered (Chaffey, 2010). Following 
this, organelles continued to be observed in microscopy studies, starting with 
the discovery of mitochondria in the 1850s by Rudolph Albert von Kolliker 
(Ernster and Schatz, 1981). Since these initial observations, many more 
organelles were discovered and their functions continue to be elucidated. 
One important organelle is the peroxisome, originally termed “microbody”. 
Peroxisomes were first discovered in 1954 by Johannes Rhodin whilst 
investigating mouse kidney cells through electron microscopy (EM) (Rhodin, 
1954). Although first thought to have no independent function and regarded as 
“fossil organelles”, it is now widely understood that these organelles play 
essential roles in human health and disease. This insight was first provided 
following the isolation of peroxisomes from rat liver cells in 1966 by Christian De 
Duve and Pierre Baudhuin which led to the discovery that peroxisomes 
contained hydrogen peroxide-producing oxidases and a hydrogen peroxide-
degrading enzyme, catalase (De Duve and Baudhuin, 1966). Furthermore, the 
development of a specific cytochemical staining for peroxisomes for light and 
electron microscopy, alkaline 3, 3′-diaminobenzidine (DAB) reaction which 
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stains catalase (Fahimi, 1968; Novikoff and Goldfischer, 1969), led to the 
discovery that peroxisomes are ubiquitous organelles amongst eukaryotic 
organisms (Hruban et al., 1972).  
Mammalian peroxisomes are 0.1-1 µm in size (Schrader and Fahimi, 2008) and 
are found in all eukaryotic cells with the highest abundance in cells of the liver 
and kidney (Vasko, 2016). They have a single membrane surrounding a 
granular matrix and they play a critical role in a variety of metabolic processes, 
such as fatty acid oxidation, ether-lipid biosynthesis, glyoxylate detoxification 
and the metabolism of reactive oxygen species (ROS) (Delille et al., 2006). In 
response to the needs of the cell, peroxisomes can rapidly alter their number by 
growth and division and a specialised form of autophagy, called pexophagy. 
Defects in this process and in the metabolic processes within peroxisomes have 
been linked to the onset of severe neurodegenerative disorders (Costello and 
Schrader, 2018). Moreover, peroxisomes have recently been identified to 
physically tether to the endoplasmic reticulum (ER), another essential organelle, 
in order to perform some of its critical functions (Costello et al., 2017a; Hua et 
al., 2017). 
1.1 Peroxisome biogenesis: 
Peroxisome biogenesis includes the growth and division of pre-existing 
organelles, the synthesis of new organelles and the import of matrix proteins. In 
mammals, these processes require the coordinated activity of PEX proteins, or 
peroxins, encoded by their corresponding PEX genes (Braverman et al., 2013). 
As peroxisomes do not contain any DNA, all peroxisomal proteins are encoded 
by nuclear DNA and are synthesised on free polyribosomes before being 
imported post-translationally (Lazarow and Fujiki, 1985). Peroxisomes require 
matrix proteins in order to carry out their numerous biochemical functions. Most 
matrix proteins in humans are imported into peroxisomes via a C-terminal PTS1 
targeting signal. This was first identified due to the presence of this signal on 
luciferase of the firefly Photinus pyralis. Within this organism luciferase targets 
to peroxisomes where it initiates a bioluminescent reaction (Gould et al., 1987; 
Keller et al., 1987). Most peroxisomal matrix proteins have a C-terminal PTS1 
signal and few have an N-terminal PST2 signal. Unlike other organelles, such 
as the ER or mitochondria, peroxisomes are able to import fully folded, co-
factor-bound or oligomeric proteins through shuttling receptors (Léon et al., 
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2006). Peroxisomal matrix proteins containing a PTS1 or PTS2 targeting signal 
are recognised by soluble receptors PEX5 and PEX7 respectively. These are 
found in the cytosol where they bind PTS1/2-containing proteins and guide 
them along the cytoskeleton to dock at the peroxisomal membrane by binding 
PEX13 and PEX14 (Braverman et al., 2013). Following transport of these cargo 
proteins into the lumen of the peroxisome, the proteins are released and the 
PEX5/7 receptors are shuttled back into the cytosol (Hasan et al., 2013) (Fig. 
1.1). The process of translocation of folded proteins across the membrane and 
cargo release is not well understood. It has been postulated that a pinocytosis-
like mechanism underlies this process (McNew and Goodman, 1996), however, 
this idea has been superseded by the “transient pore” model (Erdmann and 
Schliebs, 2005). This model suggests that a pore is dynamically formed by the 
import receptors to allow translocation and release of cargo although the exact 
mechanisms of this process remain to be fully elucidated.  
 
Fig. 1.1. Schematic overview of the molecular machineries involved in 
peroxisome biogenesis (From: Costello and Schrader, 2018) 
The import of peroxisomal membrane proteins (PMPs) is not as well 
characterised. The import of PMPs depends on their internal membrane 
targeting sequences (mPTS) and requires the peroxins, PEX3 and PEX19 and 
18 
 
also PEX16 in mammals. The mPTS contains a PEX19 binding site and a 
membrane anchoring sequence (Van Ael and Fransen, 2006). PEX19 is 
thought to bind to the PMPs in the cytosol where it is then recruited by the 
peroxisome membrane receptor PEX3 (Fujiki et al., 2006). The role of PEX16 is 
less well understood, but it is thought to function as a tethering factor for PEX3 
(Honsho et al., 2002; Fang et al., 2004) (Fig. 1.1). 
In order to adapt to suit the needs of the cell, it is essential that peroxisomes 
can increase or decrease their abundance. This requires dynamic processes 
such as biogenesis to increase their number and pexophagy to reduce their 
number (Costello and Schrader, 2018). This functional plasticity is essential, as 
indicated by the occurrence of peroxisome biogenesis disorders (PBDs) which 
are severe neurodegenerative disorders that manifest if there is a defect in any 
of these processes (Delille et al., 2006). An increase in peroxisome proliferation 
is triggered by a member of the subfamily of ligand-dependent nuclear 
transcription factors, peroxisome proliferator-activated receptor α (PPARα). This 
is activated by lipid ligands such as fatty acids and synthetic peroxisome 
proliferators and regulates the expression of genes associated with peroxisomal 
fatty acid β-oxidation and peroxisome proliferation (Schrader et al., 2013). The 
first model of peroxisome biogenesis was the “growth and division” model that 
was first proposed in 1985 (Lazarow and Fujiki, 1985). This suggested that 
peroxisomes divide and replicate autonomously like mitochondria and 
chloroplasts through the import of membrane and matrix proteins synthesised 
on free polyribosomes and inserted post-translationally into the pre-existing 
peroxisomes (Lazarow and Fujiki, 1985). This model also suggested that it was 
not possible for peroxisomes to form de novo, however, it is now widely 
accepted that peroxisome biogenesis can also occur de novo from interactions 
with neighbouring organelles. This new model was first initiated following a 
series of experiments involving mutations of peroxins PEX3, PEX16 and 
PEX19. These are required to maintain the peroxisomal membrane and their 
loss of function leads to a lack of peroxisomes (South and Gould, 1999; 
Hettema et al., 2000; Heiland and Erdmann, 2005). Re-introduction of functional 
copies of these proteins led to de novo generation of peroxisomes, suggesting 
that peroxisomes must derive from another cellular compartment (Hoepfner et 
al., 2005; Kragt et al., 2005; Haan et al., 2006; Kim et al., 2006). Subsequently, 
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it was found that PEX3 originally localises to the ER prior to peroxisome 
formation (Hoepfner et al., 2005; Haan et al., 2006), indicating a role for the ER 
in this model of peroxisome biogenesis. The exact mechanisms for ER-derived 
peroxisome biogenesis have remained a source of controversy in the field. It 
was first suggested, following studies in the yeast Saccharomyces cerevisiae, 
that PEX3 first localises to the ER before attracting PEX19 to mark the site for 
insertion of other PMPs, initiating the formation of fully competent peroxisomes 
(Hoepfner et al., 2005). Further studies showed that several other PMPs 
localise to the ER in pex3 mutant cells (van der Zand et al., 2010) and, following 
reintroduction of functional PEX3 proteins, incorporate into preperoxisomal 
vesicles which fuse to form peroxisomes (van der Zand et al., 2012). However, 
this model was challenged following the finding that PEX3 is not required for the 
formation of preperoxisomal vesicles (Knoops et al., 2014). Recent work has 
aided our understanding of this process, however, by showing that 
preperoxisomal vesicles originate at the ER in regions containing PEX30 and 
that their size and number is regulated by the actions of both PEX30 and 
PEX31, strengthening the argument for the role of the ER in peroxisome 
biogenesis (Joshi et al., 2016).  
It was recently identified that mitochondria also play a role in de novo 
peroxisome biogenesis (Sugiura et al., 2017). This study investigated de novo 
peroxisome biogenesis using human fibroblast cell lines lacking PEX3 or 
PEX16. Following reintroduction of PEX3, it was found that this peroxin targeted 
mitochondria and exited in preperoxisomal vesicles. Conversely, PEX16 
localised to the ER and was released in vesicles which fused with the 
mitochondria-derived pre-peroxisomes to form new peroxisomes (Sugiura et al., 
2017). This finding demonstrated a potential role for mitochondria in the de 
novo formation of peroxisomes, consistent with theories that peroxisomes have 
evolved from the mitochondria and corroborating the idea of a functional 
endomembrane system within eukaryotic cells (Bolte et al., 2015; Gould et al., 
2016). 
Despite the novel insights into the de novo biogenesis of peroxisomes, it is still 
widely accepted that peroxisome number is mainly controlled via growth and 
division of pre-existing organelles (Motley and Hettema, 2007). This pathway 
requires remodelling and expansion of the peroxisomal membrane which occurs 
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through the formation of tubular membrane extensions which constrict and 
divide into new peroxisomes (Schrader et al., 2016). The peroxisomal protein 
PEX11β plays an integral role in this process. PEX11β deforms and elongates 
the peroxisomal membrane prior to fission (Delille et al., 2010) and also aids in 
the assembly of the fission machinery. The fission machinery consists of the 
dynamin-like GTPase DRP1 and the membrane adaptors MFF and FIS1 
(Schrader et al., 2016). PEX11β also acts as a GTPase activating protein for 
DRP1, enabling the process of peroxisomal fission (Williams et al., 2015) (Fig. 
1.1). Many of these fission machinery proteins are also shared with 
mitochondria, which further substantiates the idea of the peroxisome-
mitochondria connection (Schrader et al., 2015). In addition, patients with a 
defect in PEX11β have also been identified. These patients display symptoms 
including neurological defects, progressive hearing loss, skeletal abnormalities 
and eye problems, however, all biochemical parameters commonly used for 
diagnosing peroxisomal disorders are normal (Ebberink et al., 2012; Taylor et 
al., 2017). This suggests that the symptoms observed are caused by a lack of 
control of peroxisome number in response to physiological cues, highlighting 
the importance of regulating peroxisome abundance (Costello and Schrader, 
2018). 
To maintain peroxisome homeostasis and ensure that peroxisomes can 
efficiently carry out their essential biochemical functions, peroxisomes also 
need to be degraded to regulate their number. Pexophagy is a specialised form 
of autophagy which allows for the selective degradation of peroxisomes 
(Yorimitsu and Klionsky, 2005). The molecular mechanisms underlying 
pexophagy have not been fully characterised, although, it is understood that 
pexophagy can be triggered by different mechanisms (Cho et al., 2018). Firstly, 
pexophagy can be mediated by ubiquitination of PMPs. In this case, ubiquitin 
bound to PMPs is exposed to the cytoplasm and can be targeted by ubiquitin-
binding autophagy adaptors, such as p62. This triggers targeting of 
peroxisomes to autophagosomes which fuse to lysosomes allowing degradation 
of peroxisomes (Kim et al., 2008). Additionally, the protein NBR1 induces 
peroxisome clustering and targeting to lysosomes to induce pexophagy 
(Deosaran et al., 2013). It has been speculated that 65% of all cases of PBDs 
are caused by the inability to prevent pexophagy, leading to a lack of 
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peroxisomes in the cell (Law et al., 2017; Nazarko, 2017). This is because the 
AAA ATPase complex consisting of the peroxins PEX1, PEX6 and PEX26 
which is mutated in many PBDs, prevents pexophagy (Law et al., 2017). The 
accuracy of this speculation remains controversial in the field, suggesting 
further research into the importance of pexophagy in health and disease is still 
required.  
1.2 Biochemical roles played by peroxisomes: 
Peroxisomes play many important roles in human metabolism and are, 
accordingly, vital for human health and development. This is highlighted by the 
occurrence of severe diseases caused by a lack of peroxisomes (PBDs) or by 
deficiencies in essential peroxisomal metabolic enzymes (Wanders, 2004).  
1.2.1 Fatty acid β-oxidation: 
One of the main roles played by peroxisomes is fatty acid β-oxidation. The 
distinct difference between mitochondrial and peroxisomal fatty acid β-oxidation 
is that peroxisomes can only chain shorten fatty acids and cannot fully degrade 
them. In mitochondria, the β-oxidation pathway removes a two-carbon unit from 
the fatty acid in the form of an acetyl-CoA unit which can then be degraded in 
the Krebs cycle to CO2, H2O and ATP. However, peroxisomes lack a Krebs 
cycle so are unable to degrade the acetyl-CoA units. For this reason, 
peroxisomes transfer their β-oxidation products to the mitochondria for complete 
degradation (Wanders et al., 2001a). Additionally, very long chain fatty acids 
(VLCFAs) (≥C22) can only be metabolised in peroxisomes. This includes 
hexacosanoic acid (C26:0), pristanic acid (obtained from dietary sources or as a 
product from the α-oxidation of phytanic acid) and di- and 
trihydroxycholestanoic acid (DHCA and THCA) which are intermediates in the 
formation of bile acids. Peroxisomal fatty acid β-oxidation also functions in the 
biosynthesis of polyunsaturated fatty acids, such as docosahexaenoic acid from 
linolenic acid in cooperation with the ER (Wanders, 2004). 
1.2.2. Biosynthesis of ether-phospholipids: 
Another essential role played by peroxisomes is the biosynthesis of ether-
phospholipids. These are a special class of phospholipids that have an ether 
linkage at the sn-1 position of the glycerol backbone rather than an ester 
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linkage as in diacylglycerophospholipids. Certain ether-phospholipids are known 
as plasmalogens which are constituents of many tissues in the body, including 
brain myelin which is required for normal neurological function and also heart 
muscle, skeletal muscle and kidneys. In the peroxisomal biogenesis disorder 
rhizomelic chondrodysplasia punctata (RCDP), plasmalogen synthesis is 
severely impaired due to the lack of PTS2-mediated import of alkyl-
dihydroxyacetone phosphate synthase (ADHAPS) caused by a mutation in the 
gene encoding the peroxisomal protein transporter, PEX7 (Brites et al., 2004). 
Plasmalogen biosynthesis starts in peroxisomes and involves the esterification 
of dihydroxyacetone phosphate (DHAP) with a long-chain acyl-CoA ester and is 
carried out by dihydroxyacetone phosphate acyltransferase (DHAPAT) (Hajra, 
1997). The ether bond at the sn-1 position is introduced by the replacement of 
the sn-1 fatty acid with a long-chain fatty alcohol. This is catalysed by ADHAPS 
and produces alkyl-DHAP (Brown and Snyder, 1982; Singh et al., 1993). Both 
DHAP and ADHAPS are strictly peroxisomal enzymes (Singh et al., 1993). The 
ketone group at the sn-2 position of alkyl-DHAP is then reduced by acyl/alkyl-
dihydroxyacetone phosphate reductase (AADHAP-R), which has a bimodal 
distribution in peroxisomes and the ER (Ghosh and Hajra, 1986; Datta et al., 
1990). This results in the formation of 1-alkyl-sn-glycero-3-phosphate which 
undergoes conversion into mature plasmalogens in the ER (Braverman and 
Moser, 2012). 
1.2.3. Fatty acid α-oxidation: 
Fatty acids which have a methyl group at the β-position cannot directly undergo 
β-oxidation. Instead, these fatty acids need to first be α-oxidised to remove their 
terminal carboxyl group as CO2. One such fatty acid which requires metabolism 
in this way is phytanic acid. The α-oxidation of phytanic acid begins with its 
activation to phytanoyl-CoA, via the long-chain acyl-CoA synthetase (LACS) 
localised on the peroxisomal membrane. Following uptake into the peroxisomal 
matrix, phytanoyl-CoA undergoes hydroxylation and cleavage to pristanal and 
formyl-CoA. Pristanal is then converted into pristanic acid which undergoes 
three cycles of β-oxidation within the peroxisome before being fully oxidised in 
the mitochondria. Phytanic acid is known to accumulate in Refsum disease due 
to a defect in this process (Wanders et al., 2001b). 
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1.2.4. Reactive oxygen species (ROS) metabolism: 
Reactive oxygen species (ROS) are oxygen-derived radical species. They play 
an essential role in physiological conditions such as the mediation of cell 
signalling, host defence and ageing (Bonekamp et al., 2009). However, their 
overproduction under conditions of oxidative stress can cause detrimental 
effects on the cell and has been linked to conditions such as cancer, 
neurodegeneration and atherosclerosis (Schrader and Fahimi, 2006). 
Peroxisomes have been identified as key players in ROS metabolism due to 
their ability to both generate and break down ROS. Essential cellular metabolic 
processes involving peroxisomes, such as fatty acid β-oxidation, are known to 
produce hydrogen peroxide (H2O2). H2O2 is often associated with ROS due to 
its potential to be easily converted into radical species, for example, into OH 
via Fenton-catalysed reduction. In addition, peroxisomes contain other ROS-
producing oxidases (Bonekamp et al., 2009). Interestingly, peroxisomes also 
contain several ROS-degrading enzymes, such as catalase, glutathione 
peroxidase, manganese superoxide dismutase, epoxide hydrolase and 
peroxiredoxin I, highlighting their important role in maintaining balance in 
cellular ROS levels (Schrader and Fahimi, 2006). 
1.3 Role of peroxisomes in disease:  
It has now become evident that peroxisomes are vital for human health and 
development. This is corroborated by the existence of several inherited 
peroxisomal diseases caused by defects in essential peroxisomal genes 
(Waterham et al., 2016). These diseases often present with severe phenotypes 
and can affect the brain, spinal cord, eyes, ears, liver, kidney, adrenal cortex 
and skeletal system amongst other organs (Gould and Valle, 2000). 
Peroxisomal diseases generally fall into two categories; single enzyme 
deficiencies which may affect one specific peroxisomal function or metabolic 
pathway, and the peroxisome biogenesis disorders (PBDs) in which the affected 
protein is a peroxin (Waterham et al., 2016). PBDs vary in severity, but they 
usually result in either impairment or completely inhibition of peroxisome 
function. In some cases, PBDs can lead to the formation of peroxisomal 
“ghosts” which are empty, non-functional peroxisomal membranes. This occurs 
as many peroxins are involved in protein import, so a defect in these proteins 
renders peroxisomes unable to take up peroxisomal matrix proteins from the 
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cytosol, resulting in peroxisomes being unable to carry out their essential 
biochemical functions. This ultimately leads to an accumulation of peroxisomal 
substrates, such as, VLCFAs, pristanic and phytanic acids, bile acid 
intermediates and pipecolic acid, which can be toxic to the cell. There is also a 
lack of essential peroxisomal-derived products such as plasmalogens which are 
required for normal neurological function (Delille et al., 2006). 
1.3.1. Peroxisome biogenesis disorders: 
PBDs are autosomal-recessive diseases which consist of two broad clinical 
spectra; the Zellweger spectrum, which accounts for 80% of all occurrences of 
PBDs, and the rhizomelic chondrodysplasia punctata (RCDP) spectrum 
(Rosewich et al., 2005). The most severe Zellweger spectrum class is Zellweger 
Syndrome, first described in 1964 by Bowen et al (Bowen et al., 1964). It is a 
rare disease affecting 1:50,000 births and is characterised by an absence of 
peroxisomes (Goldfischer et al., 1973). Affected patients usually present with 
neonatal hypotonia, craniofacial dysmorphy, hepatomegaly, renal cysts, adrenal 
atrophy and neurological abnormalities (Waterham et al., 2016). These patients 
also show distinct biochemical parameters such as an increased level of 
VLCFAs, bile acid intermediates, pipecolic and phytanic acid in the blood. 
Patients with Zellweger syndrome usually do not survive past the first year of 
life. Most Zellweger spectrum disorders are caused by mutations in PEX1, an 
AAA ATPase involved in PTS1/2 protein import (Reuber et al., 1997). 
RCDP type 1 is clinically and genetically distinctive from the Zellweger 
syndrome spectrum and was first described in 1985 (Heymans et al., 1985). 
This spectrum includes RCDP type 1, and also milder variants. RCDP type 1 is 
caused by mutations in the PEX7 gene encoding the PEX7 cytosolic receptor. 
This disrupts the import of PTS2-containing proteins, such as, alkyldihydroxy-
acetonephosphate synthase (ADHAPS) involved in the synthesis of 
plasmalogens. Patients present with shortening of the limbs, cataracts and 
psychomotor retardation (Rosewich et al., 2005) and do not usually survive past 
the first decade of life (Wanders and Waterham, 2004). 
1.3.2. Single peroxisomal enzyme deficiencies: 
The single peroxisomal enzyme deficiencies differ from PBDs as the defect is 
not in a PEX gene. The clinical symptoms presented by affected patients result 
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from a deficiency in a peroxisomal enzyme involved in a specific anabolic or 
catabolic pathway (Aubourg and Wanders, 2013). The most common single 
peroxisomal enzyme deficiency is X-linked adrenoleukodystrophy (X-ALD) with 
an estimated incidence of 1:17,000 (Kemp et al., 2012). X-ALD is caused by a 
mutation in the ABCD1 gene which encodes an ATP-binding cassette (ABC) 
transporter protein of the peroxisomal membrane, called ABCD1 or ALDP, 
which plays a role in the uptake of VLCFAs (Mosser et al., 1993).  
In addition to X-ALD, there are also several other single peroxisomal enzyme 
deficiencies which affect peroxisomal fatty acid β-oxidation. These include: acyl-
CoA-oxidase-1 (ACOX1) deficiency (Poll-the et al., 1988) and D-bifunctional 
protein (DBP) deficiency (Suzuki et al., 1997), both characterised by the 
accumulation of VLCFAs (Wanders and Waterham, 2006). Additionally, 2-
methylacyl-CoA racemase (AMACR) deficiency (Ferdinandusse et al., 2000) 
and sterol carrier protein X (SCPx) deficiency (Ferdinandusse et al., 2006) have 
been identified which are both associated with an increase in the levels of 
phytanic and pristanic acid as well as DHCA and THCA, however, there is no 
accumulation of VLCFAs (Wanders and Waterham, 2006).  
1.4 Membrane contact sites: 
We now know that eukaryotic organelles do not operate as separate entities, 
rather they cooperate extensively in order to efficiently carry out their functions. 
This is made possible through vesicular trafficking pathways and membrane 
contact sites (MCS). MCSs are sites of close apposition between two or more 
organelles which allows the exchange of materials such as metabolites, lipids 
and proteins (Cohen et al., 2018). The first indication that organelles may 
interact in this way was provided by early electron microscopy studies in which 
organelles were frequently found to be closely apposed to each other at defined 
foci (Bernhard and Rouiller, 1956; Porter and Palade, 1957; Copeland and 
Dalton, 1959; Rosenbluth, 1962; Gray, 1963). Subsequent studies on the triadic 
muscle junction between the ER and plasma membrane invaginations in 
skeletal muscle cells showed that these inter-organellar connections are 
mediated through interacting proteins which act as tethers to bridge the 
respective organelle membranes (Kawamoto et al., 1986). 
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In recent years, it has become increasingly evident that most organelles interact 
in this way. Accordingly, the list of known proteins which are implicated in the 
formation or function of contact sites, is constantly expanding (Eisenberg-Bord 
et al., 2016). These proteins can have various functions. Some act to physically 
tether the interacting organelles (Csordás et al., 2006; Helle et al., 2013), whilst 
others act as mediators of metabolite exchange, for example, in the non-
vesicular exchange of small molecules (Prinz, 2014; Henne, 2016). Some 
proteins may even act to regulate the size and abundance of organelle contact 
sites in response to environmental and physiological cues (Kornmann et al., 
2011; Elbaz-Alon et al., 2014; Henne et al., 2015). It should be noted, however, 
that not all cases in which organelles are tethered in this way are considered 
true MCSs. In order to aid in the identification of bona fide MCSs, it has been 
suggested that interactions such as these must have the following four 
properties: (1) the tethered organelle membranes must be in close apposition, 
typically within 30 nm, (2) the membranes do not fuse, (3) specific proteins 
and/or lipids must be enriched at the MCS and (4) MCS formation must affect 
the function or composition of at least one of the tethered organelles (Prinz, 
2014).  
Improvements in microscopical and biochemical methods to study MCSs has 
significantly aided in their identification and advanced our understanding of their 
function. This has led to the recognition that MCSs can be implicated in several 
cellular processes. Perhaps the best studied function is the exchange of Ca2+ 
ions that occurs at several MCSs, including ER-plasma membrane, ER-
endosome and ER-mitochondria contacts (Phillips and Voeltz, 2016). An 
example of this in mammalian cells is the interaction between the voltage-
dependent anion channel (VDAC) on the outer mitochondrial membrane and 
the IP3 receptor on the ER which mediates Ca2+ homeostasis (Szabadkai et al., 
2006). In addition, almost all known MCSs have been identified to function in 
lipid transfer. For instance, the transfer of phospholipids occurs at ER-
mitochondria MCSs (Phillips and Voeltz, 2016) and the transfer of fatty acids is 
known to occur at ER-lipid droplet and lipid droplet-mitochondria MCSs (Gatta 
and Levine, 2017). In some cases, MCSs may also play a role in organelle 
division, as is the case for mitochondria which divide when the ER wraps 
around mitochondrial constriction sites (Friedman et al., 2011). Finally, MCSs 
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may also simply play a role in the arrangement of the cellular landscape, 
providing a dynamic, but controlled architecture to enable the correct targeting 
of molecules and optimise biosynthetic pathways (Shai et al., 2016).  
1.4.1. Peroxisome-organelle contact sites: 
Like other organelles, peroxisomes also participate in inter-organelle 
cooperation. For decades, it has been observed in electron microscopy images 
from fungi, plants and mammals that peroxisomes are often found juxtaposed to 
other organelles, in particular the ER, plasma membrane, lipid droplets, 
chloroplasts and mitochondria (Herzog and Fahimi, 1976; Hicks and Fahimi, 
1977; Fahimi and Yokota, 1981). These provided the first indication that 
peroxisomes may form MCSs with neighbouring organelles. In recent years, 
several peroxisome-organelle contact sites have been identified in yeast and 
mammals and we now have a greater idea of the role that they play in the cell. 
1.4.2. Peroxisome-mitochondria contacts: 
It has been long understood that mitochondria and peroxisomes maintain a 
close relationship. Despite different evolutionary origins, both organelles are 
morphologically and functionally similar (Schrader and Yoon, 2007). In recent 
years, it has been uncovered that this organelle relationship may be closer than 
originally proposed. Cooperation between these organelles includes fatty acid 
β-oxidation in which mitochondria fully degrade fatty acids which have been 
partially degraded in peroxisomes (Wanders et al., 2001a) (see Section 1.2.1 
for further detail). Additionally, both organelles share key proteins of their 
division machinery such as DRP1, FIS1 and MFF (Schrader et al., 2012). 
Mitochondria and peroxisomes have also been shown to cooperate in 
maintaining redox balance in the cell (Fransen et al., 2012) as well as cooperate 
in antiviral signalling and defence (Odendall and Kagan, 2013). Moreover, a 
vesicular trafficking pathway between peroxisomes and mitochondria has also 
been identified which could allow direct cargo exchange between both 
organelles (Neuspiel et al., 2008). Recently, some peroxisome-mitochondria 
contact sites have been proposed in yeast. In 2015, a genome-wide localisation 
study of the peroxisomal protein PEX11 identified that this protein may interact 
and form a peroxisome-mitochondria tether with mitochondrial MDM34, a 
protein involved in the yeast mitochondria-ER tethering complex, ERMES 
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(Mattiazzi Ušaj et al., 2015). In 2018, a new peroxisome-mitochondria contact 
site was uncovered in yeast. This contact site, named “PerMit” consists of two 
tethering proteins, peroxisomal PEX34 and mitochondrial FZO1 and has been 
demonstrated to play a role in fatty acid β-oxidation (Shai et al., 2018). In 
mammals, the ACBD2/ECI2 protein, which has been reported to be shared 
between both peroxisomes and mitochondria, has been suggested to play a 
role in enabling contact between the two organelles, but this has not been 
extensively studied (Fan et al., 2016). The observed proximity and extensive 
cooperation between the organelles, however, make the existence of a bona 
fide tethering complex likely. Furthermore, in the yeast S. cerevisiae, 
peroxisomes have been found adjacent to a mitochondrial niche in which the 
mitochondria-ER contact occurs (Cohen et al., 2014). The proximity of these 
three organelles has led to the hypothesis that they may form a “tripartite” 
contact site, allowing bi-directional transfer of molecules between the organelles 
simultaneously (Shai et al., 2016). More research in this area is needed to fully 
uncover the components and mechanisms involved in mammalian peroxisome-
mitochondria contact sites and further investigate the possibility of a tripartite 
contact site. 
1.4.3. Peroxisome-lipid droplets contacts: 
Lipid droplets (LDs) are dynamic organelles found in eukaryotic cells. They 
contribute to many cellular functions and act as a store for neutral lipids such as 
triacylglycerol and cholesterol ester (Beller et al., 2010). Early ultrastructural 
studies first suggested an interaction between LDs and peroxisomes (Novikoff 
et al., 1980) and this has since been confirmed by live cell imaging (Schrader, 
2001). It has been postulated that the peroxisome-LD interaction may link 
lipolysis mediated by LDs to peroxisomal fatty acid β-oxidation and that lipids 
generated by peroxisomes may move into LDs (Schrader et al., 2013). In 
support of this, a study in the nematode Caenorhabditis elegans found that 
defects in peroxisomal fatty acid β-oxidation resulted in enlarged LDs (Zhang et 
al., 2010). Additionally, changes in the size and number of LDs have been 
observed in peroxisome-deficient knock-out mice (Dirkx et al., 2005). Despite 
these observations, a peroxisome-LD tether has yet to be identified. In S. 
cerevisiae, an interactome map of protein-protein interactions between 
peroxisomes and LDs was generated which revealed that the LD proteins 
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ERG6 and PET10 interact with several peroxisomal proteins (Pu et al., 2011), 
however, whether these proteins constitute a genuine tether has not yet been 
determined. 
1.4.4. Peroxisome-lysosome contacts: 
Lysosomes are ubiquitous organelles best known for their role in the digestion 
of intracellular components such as autophagic organelles (Muffly, 2007). They 
also provide a major source for cellular cholesterol (Jin et al., 2015). In 2015, 
the first peroxisome-lysosome contact site was discovered. The integral 
lysosomal membrane protein, synaptotagmin VII (Syt7) was shown to bind to 
the lipid PI(4,5)P2 on the peroxisomal membrane. (Jin et al., 2015). This contact 
is required for the transport of cholesterol from the lysosome to the plasma 
membrane (Chu et al., 2015). Cholesterol accumulation in lysosomes has been 
observed in cells from patients suffering from the peroxisomal diseases X-ALD 
and Zellweger spectrum disorders, highlighting the importance of peroxisome-
lysosome contact for cholesterol transport (Shai et al., 2016). 
1.4.5. Peroxisome-peroxisome contacts: 
Peroxisomes have also been found to self-interact in transient and long term 
contacts in live cell studies (Bonekamp et al., 2012) and in ultrastructural 
studies where the presence of small peroxisome groups with close apposition 
have been observed (Zaar et al., 1984; Stier et al., 1998). The physiological role 
for this interaction is not well understood, although it has been hypothesised 
that these interactions may provide a “signalling system” to the cell to monitor 
the state and distribution of peroxisomes to ensure that their population is stably 
maintained (Schrader et al., 2013). Functionally, these contacts may be 
required for the exchange of metabolites, such as H2O2 or other ROS. The close 
interaction between the peroxisomes may allow efficient exchange of these 
species and minimise leakage (Shai et al., 2016). Furthermore, peroxisomes 
moving along microtubules in the cell have been observed to interact with other 
peroxisomes (Schrader et al., 2013). The exact mechanisms underlying 
peroxisomal self-interaction have yet to be uncovered. 
1.4.6. Peroxisome-ER contacts: 
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By far the best studied peroxisome-organelle contact is that between 
peroxisomes and the ER. Early ultrastructural studies revealed that 
peroxisomes are found in close proximity to the ER and in some cases they are 
even wrapped in ER cisternae (Novikoff and Novikoff, 1972; Zaar et al., 1987; 
Grabenbauer et al., 2000). Originally, the close apposition of these two 
organelles was hypothesised to be involved in the formation of new 
peroxisomes (Novikoff and Shin, 1964), an idea which has subsequently been 
corroborated following elucidation of the role of the ER in de novo peroxisome 
biogenesis. As well as contributing to de novo formation of peroxisomes, the ER 
has also been found to play a role in the non-vesicular delivery of phospholipids 
to nascent peroxisomes to enable membrane growth when peroxisomes divide 
by growth and division (Raychaudhuri and Prinz, 2008; Hettema et al., 2014). 
In addition to contributing to the biogenesis of peroxisomes, the ER has also 
been implicated in several essential biochemical processes which occur in 
peroxisomes. An example of such is the biosynthesis of plasmalogens which is 
initiated in peroxisomes but requires further reactions in the ER for completion 
(Braverman and Moser, 2012) (see Section 1.2.2 for further detail). The 
production of polyunsaturated fatty acids, such as docosahexaenoic acid, also 
requires cooperation between the two organelles. Fatty acids produced in the 
ER are transferred to peroxisomes where they are partially degraded by fatty 
acid β-oxidation until a double bond is formed at position 4 of the carbon chain 
(Sprecher and Chen, 1999; Su et al., 2001). At this point, they can then be 
transported back to the ER where they can be used for membrane lipid 
biosynthesis (Sprecher and Chen, 1999). Furthermore, bile acid synthesis also 
requires cooperation with the ER. The ER contains enzymes which are 
essential for the import of THCA, a bile acid precursor, into peroxisomes where 
it can be processed by β-oxidation (Mihalik et al., 2002). Defects in any of these 
pathways have been linked to severe neurodegenerative disorders (Wanders 
and Poll-The, 2017), highlighting the importance of cooperation between these 
two organelles. 
Despite our understanding of the importance of cooperation between these two 
organelles, we have only recently started to gain insight into the formation, 
structure and function of this association. In yeast, a peroxisome-ER contact 
site (EPCON) and a peroxisome-ER tether consisting of PEX3 and INP1 
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required for inheritance have been identified (David et al., 2013; Knoblach et al., 
2013), but mammalian homologues remained undiscovered. In 2017, however, 
the first bona fide mammalian MCS between peroxisomes and the ER was 
discovered in parallel studies by two different groups (Costello et al., 2017a; 
Hua et al., 2017). It was identified that the peroxisomal membrane protein acyl-
coenzyme A–binding domain protein 5 (ACBD5) is a binding partner for the ER 
protein vesicle-associated membrane protein-associated protein B (VAPB) (Fig. 
1.2). The first suggestion that these proteins were involved in tethering the 
respective organelle membranes was made following a search for proteins 
which interact with known peroxisomal membrane proteins. Costello et al 
investigated ACBD5 as a protein of interest, whilst Hua et al investigated 
PEX16, a peroxin which has been identified to initially target to the ER before 
being trafficked to peroxisomes and is involved in peroxisome biogenesis (Kim 
et al., 2006; Aranovich et al., 2014; Hua et al., 2015). Both studies identified ER 
proteins VAPA and VAPB as candidate interactors. VAP proteins are known to 
participate in contact sites and mediate protein interactions due to the presence 
of a major sperm protein (MSP) domain within their structure (Wyles and 
Ridgway, 2004). The MSP domain is a 7-beta strand globular domain (120-140 
amino acids) which interacts with proteins that contain two phenylalanines (FF) 
in an acidic tract (FFAT) motif (Fig. 1.2). VAPA/B also contain a linker region 
(≤ 100 aa) which partly forms a coiled-coil, and a C-terminal transmembrane tail 
anchor that targets the ER (Murphy and Levine, 2016). VAPB has also been 
implicated in the neurodegenerative disorder, amyotrophic lateral sclerosis 
(ALS) which is caused by a proline-to-serine mutation in the protein at position 
56 (P56S) (Nishimura et al., 2004). ACBD5 was predicted to have a FFAT-like 
motif, further validating its potential as an interacting partner for VAPB (Murphy 
and Levine, 2016) (Fig 1.2). FFAT motifs have a core of six defined elements 
across a stretch of seven residues E1-F2-F3-D4-A5-x-E7 (using the single letter 
amino acid code, where x is any amino acid) (Loewen et al., 2003) and can bind 
to the MSP domain in VAPA/B proteins with a micromolar dissociation constant 
(Murphy and Levine, 2016). In addition, ACBD5 consists of an N-terminal acyl-
CoA binding (AcB) domain and a C-terminal transmembrane tail anchor which 
targets to the peroxisomal membrane (Costello et al., 2017a) (Fig. 1.2). 
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Fig. 1.2. Schematic model of the ACBD5–VAPB interaction (From: Costello et 
al., 2017a). 
Collectively, these studies proved that the interactions between these proteins 
constitute a genuine tether. Hua et al showed that VAP proteins were enriched 
in puncta which are localised in close proximity to peroxisomes using structured 
illumination superresolution microscopy. Both studies showed that VAPA/B and 
ACBD5 specifically mediate the organelle interactions through demonstrating 
that loss of each protein individually, particularly loss of ACBD5, leads to a 
disruption in peroxisome-ER interaction. Furthermore, it was found that this 
protein interaction occurs specifically through the FFAT-like motif of ACBD5 as 
mutations in the FFAT-like motif disrupted binding between the two proteins, 
whilst mutations in other domains had no effect on binding. Additionally, 
Costello et al demonstrated that overexpression of both proteins significantly 
increased the number of peroxisomes in close contact with the ER (<15 nm 
distance). It was also shown that interaction between these proteins is required 
for functional activity of the two organelles. A depletion in ACBD5 leads to a 
loss of tethering to the ER and subsequently increased peroxisome motility. 
Moreover, depletion of one of the tethering components also reduces 
peroxisomal membrane expansion, suggesting that the peroxisome-ER 
connection is required for the transfer of membrane lipids for peroxisomal 
growth and division. Finally, Hua et al also demonstrated that this connection 
may be implicated in lipid synthesis. A depletion in VAPA/B or ACBD5 led to an 
overall reduction in plasmalogen and cholesterol levels in the cell, suggesting 
that this tether also functions in cooperative biochemical pathways. 
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Following these studies, it was subsequently found that another tail-anchored 
peroxisomal membrane protein ACBD4, can also bind to VAPB and tether 
peroxisomes to the ER (Costello et al., 2017b). ACBD4 is also a member of the 
ACBD family and shares 58% sequence identity with ACBD5. Accordingly, 
ACBD4 also contains an N-terminal acyl-CoA binding domain and is predicted 
to contain a coiled-coil domain and FFAT-like motif. Using pull down studies 
and mass spectrometry, VAPA and VAPB were identified as potential 
interactors. Subsequent immunoprecipitation experiments confirmed the 
interaction between ACBD4 and VAPB, proving the existence of another 
peroxisome-ER tether (Costello et al., 2017b).  
1.4.7. The role of ACBD5 in health and disease: 
The exact function of ACBD5 has yet to be fully elucidated, however, it has 
recently been implicated in disease. In 2013, an exome sequencing study of 
patients with retinal dystrophy revealed ACBD5 as a novel candidate disease 
gene. Three siblings were identified with a homozygous splice site mutation in 
ACBD5 resulting in loss of function and syndromic retinal dystrophy (Abu-Safieh 
et al., 2013). This study, however, did not assess the physiological and 
functional consequences of the mutation. Additionally, a patient has been 
identified with a loss of function mutation in ACBD5 resulting in progressive 
leukodystrophy, cleft palate, ataxia and retinal dystrophy. This patient also 
presented with elevated levels of VLCFAs in the plasma, indicating defective 
fatty acid β-oxidation presumably due to insufficient uptake of VLCFAs into 
peroxisomes. This led to the suggestion that ACBD5 may function as a 
membrane-bound receptor for very-long-chain fatty acyl-CoAs (VLCFA-CoAs) 
(Ferdinandusse et al., 2017). It was postulated that the exposed AcB domain of 
ACBD5 attaches to VLCFAs in the cytosol and brings them to the VLCFA 
transporter ABCD1 on the peroxisomal membrane. This, in turn, transfers the 
VLCFAs into peroxisomes where they can be degraded by fatty acid β-oxidation 
(Ferdinandusse et al., 2017). The ability of ACBD5 to interact with ABC 
transporters remains questionable, however, as a recent study showed that 
ACBD5 fails to interact with an ABCD1 homologue, ABCD2 (Geillon et al., 
2017). ACBD5 was also suggested to play a role in pexophagy based on 
sequence similarity with the ATG37 protein of the yeast Pichia pastoris, which 
performs this function (Nazarko et al., 2014). However, subsequent studies 
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using an ACBD5 knock-out cell line and an established pexophagy assay failed 
to reveal a role for ACBD5 in this process (Ferdinandusse et al., 2017). It 
appears as if diseases associated with loss of ACBD5 are linked to a loss in its 
physiological functions, however, it has still not been established whether a 
reduction in peroxisome-ER contact, which would likely occur with loss of 
ACBD5, plays any role in the symptoms observed.  
1.4.8. The need for multiple tethers: 
The existence of more than one tether between peroxisomes and the ER is 
consistent with findings from studies on other inter-organelle contacts. For 
example, it has been reported that ER-mitochondria interactions are mediated 
by multiples tethers which are linked to different functions (Naon and Scorrano, 
2014). However, the requirement for multiple peroxisome-ER tethers has yet to 
be understood. 
As ACBD4 has been shown to be functionally similar to ACBD5 in terms of 
mediating peroxisome-ER tethering, it would be tempting to speculate that loss 
of ACBD5 could be complemented by ACBD4. However, this seems unlikely 
based on the severe consequences associated with a loss of function of ACBD5 
in patients (Abu-Safieh et al., 2013; Ferdinandusse et al., 2017). This is also 
corroborated by the finding in the ACBD5-VAPB interaction study by Costello et 
al where knockdown of ACBD5 in HepG2 cells significantly reduces 
peroxisome-ER contacts (Costello et al., 2017a). ACBD4 is also reported to be 
expressed in these cells (Yang et al., 2016), so if it was capable of 
complementing the function of ACBD5, this significant reduction would not have 
occurred. This suggests that ACBD4 and ACBD5 may have distinct 
physiological functions separate from mediating tethering between peroxisomes 
and the ER, leading to the requirement of both proteins. It has also been 
hypothesised that ACBD5 may act as the major tether for peroxisome-ER 
contacts, whereas ACBD4 may play a role in more specialised peroxisome-ER 
contacts (Costello et al., 2017b). Our current understanding of contact sites in 
peroxisomes and in other organelles suggests that it would be likely that there 
are other proteins which act as tethers for peroxisome-ER associations. 
However, to date, the available tools for deciphering novel contact site proteins 
are lacking. For this reason, it has become essential to devise new methods to 
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identify the proteins involved in order to fully elucidate the function of this 
organelle cooperation.  
1.5 Visualising contact sites: 
Our extensive findings in the field of inter-organelle contacts and our increased 
understanding of the relevance of this phenomenon in both health and disease 
have paved the way for a new, exciting area of organelle research. However, 
many questions remain unanswered. It is currently unclear whether we have 
identified all of the existing inter-organelle contact sites. The observed proximity 
and established physiological cooperation between most organelles suggest we 
have only touched the surface. Additionally, the coordination and regulation 
behind the formation of contact sites has yet to be elucidated. Moreover, the 
function of many known contact sites has still not been fully characterised. 
These questions have led to a drive to establish simple, yet robust methods to 
aid in the discovery of novel contact sites and further our understanding of 
existing sites. Our understanding of these sites depends on the quality and 
availability of the tools we have to study them. To this end, the number of tools 
created and optimised for this use has increased in recent years.  
In order to first identify organelles which are in close proximity, microscopy 
methods are required. The size of contact sites is generally within the range of 
10-40 nm which is well below the diffraction limit of conventional light 
microscopy (Eisenberg-Bord et al., 2016). Consequently, imaging these sites 
requires more specialised microscopy methods such as electron microscopy 
(EM). EM provides a much higher resolution (Dresser, 2001) and much higher 
magnification (between x10 and x1,000,000) than light microscopy (Goldberg 
and Fiserova, 2010) which allows for efficient imaging of close contact between 
organelles. In order to further characterise the morphology of contact sites, 
electron cryo-tomography (cryo-ET) has been used increasingly. This method 
allows thin samples to be imaged in three-dimension in a nearly native state to 
~4 nm resolution (Tocheva et al., 2010). Importantly, this method was used to 
investigate mitochondria-ER contacts sites. Analysis with cryo-ET revealed that 
ER tubules tightly wrap around mitochondria, indicating the important role for 
these contact sites in mitochondrial division (Friedman et al., 2011; Murley et 
al., 2013). Furthermore, cryo-ET has also been used to directly visualise tether 
structures between two organelle membranes in situ. In fractionated rat liver 
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cells, structures with no molecular identification which connect the mitochondrial 
outer membrane to the ER have been observed (Csordás et al., 2006). 
Additionally, more advanced EM techniques such as Focused Ion Beam 
Scanning EM (FIB-SEM) have been employed. FIB-SEM uses a focused ion 
beam to collect an image whilst simultaneously milling the specimen surface 
(Cohen et al., 2018). This has been used to visualise contacts between the ER 
and other organelles, including mitochondria, peroxisomes and the plasma 
membrane in neurons (Wu et al., 2017). Despite the unparalleled spatial 
resolution offered by these microscopy techniques, their advantages are offset 
by the requirement for samples to be fixed. As we know that contact site 
formation can often be dynamic and transient, a method to visualise contacts in 
live cells and in real-time is required to fully understand these structures (Cohen 
et al., 2018). In addition, ultrastructural imaging methods are often time-
consuming and required specialised equipment and expertise, rendering them 
an expensive method which may not be accessible for all research groups 
(Choudhary and Priyanka, 2017). 
To enable dynamic, real-time analysis of contact sites with molecular specificity, 
the use of genetically encoded fluorescent fusion proteins is often employed 
(Cohen et al., 2018). When fused to a protein of interest, for example, a protein 
known to localise to contact sites, the resulting fluorescence can be observed 
using fluorescence microscopy at the resolution of standard light microscopy. 
During fluorescence microscopy, the protein of interest is fused to a fluorescent 
protein, such as green fluorescent protein (GFP) or red fluorescent protein 
(RFP), which contains a fluorophore. If the fused protein is a contact site 
protein, this could provide indication of number of contact sites present. 
Moreover, when this technique is employed in live cell imaging, the dynamic 
nature of the protein and related contact site can also be assessed.  
Similarly, immunofluorescent methods are often utilised. These methods 
capitalise on the wide range of monoclonal antibodies available which are 
specific to a protein of interest and can only be conducted in fixed cell samples. 
Indirect immunofluorescence is most commonly used which allows the 
localisation and abundance of a protein to be determined and can be applied to 
assess known contact site proteins. Immunofluorescent methods, generally, are 
much less laborious and time consuming than fluorescent fusion protein-based 
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methods as they do not require the complex process of molecular cloning and 
transformation into cells (Celler et al., 2016), however, their requirement to be 
carried out in fixed cells limits their application in the study of protein dynamics. 
Increasingly, methods optimised for the study of protein-protein interactions 
have been applied to the study of organelle contact sites. An example of this is 
the use of proximity ligation assays (PLA), also known as “Duolink®”. This 
system relies on the targeting of two primary antibodies to two proteins which 
are hypothesised to be in close proximity. The output of this system is a 
fluorescent signal which can be visualised by fluorescence microscopy 
(Gullberg and Andersson, 2010). This system and its use in the study of contact 
sites is described in detail in Section 3.1. 
Another method of this type is bimolecular fluorescence complementation 
(BiFC). This method has offered a more sophisticated approach to studying 
contact sites. BiFC consists of a split fluorescent protein technology such as 
split Venus, dimerisation-dependent GFP and split superfolder GFP. In these 
systems, two non-fluorescent portions of a fluorescent protein are fused to 
abundant membrane proteins or known tethering proteins on two interacting 
organelles. When the two halves of fluorescent protein are brought in close 
proximity, through contact of the respective organelle membranes, fluorescence 
is restored and can be used as a measure of organelle contact (Harmon et al., 
2017). These systems have allowed for the study of the dynamics of contact 
site formation in live cells (Alford et al., 2012a) and can also be employed in 
fixed cells to assess changes in contact sites following alterations in 
physiological cellular conditions (Cieri et al., 2018). For this reason, these 
systems have been used extensively in contact site studies and are described 
in detail in Section 4.1. 
Fluorescence resonance energy transfer (FRET) is a similar method to BiFC 
and is also commonly used in the study of contact sites. FRET is a molecular 
imaging technique in which a donor fluorophore fused to one protein transfers 
energy to an acceptor fluorophore fused to another protein. If these proteins are 
in close proximity (≤10 nm distance), fluorescence will be produced indicating 
contact between the organelles (Cohen et al., 2018). This can be performed by 
attaching fluorophores to known membrane proteins on the organelles of 
interest, meaning that the knowledge of specific tethering proteins is not 
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required. This method has been previously used to assess mitochondria-ER 
contact sites (Csordás et al., 2010). Unfortunately, the occurrence of 
photobleaching and intrinsic autofluorescence of the cells examined can limit 
the usefulness of FRET. In addition, excitation of the acceptor fluorophore 
directly has been known to occur in some cases, leading to false-positive 
results (Xu et al., 1999).  
Despite the advances in the creation and optimisation of all of the above 
methods, they all still have their own respective limitations. A criticism of 
fluorescence-based studies and imaging in general for the investigation of 
contact sites is that any observed co-localisation or proximity between 
organelles is not necessarily indicative of a functional contact site (Cohen et al., 
2018). Therefore, these techniques should be combined with additional 
techniques, such as biochemical methods, to confirm the organelle interaction. 
Biochemical methods are often employed as a preliminary step to identify 
interacting proteins implicated in organelle contact sites. Common techniques of 
this type include the yeast two hybrid system, tandem affinity purification (TAP) 
and co-immunoprecipitation (coIP) (Rao et al., 2014). Co-IP is most commonly 
used and requires a whole cell extract where proteins are present in their native 
form (Rao et al., 2014). A drawback of biochemical methods in general, 
however, is that creating a cell lysate, as is required in most methods, destroys 
the environment of the protein. As organelle contact sites are highly organised 
structures, the creation of a cell lysate could compromise their integrity, making 
the identification of genuine interactions difficult (Eisenberg-Bord et al., 2016).  
1.6 Thesis aims and objectives: 
It is clear that the current toolbox for the investigation of organelle contact sites 
is expanding, however, with our growing knowledge of contact sites, there is a 
requirement to optimise these methods to allow for the study of more inter-
organelle contact sites. As peroxisome-organelle contact sites have only 
recently been identified, methods to study these sites are lacking.  
Despite our advances in the understanding of peroxisome-ER contact sites, 
many questions are still unanswered. We understand the relevance of this 
organelle contact in both health and disease, however, the mechanisms 
underlying its formation and how this is regulated has yet to be uncovered. 
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Moreover, its physiological function has not been elucidated. In order for us to 
fully understand this organelle contact we require appropriate tools which are 
simple, robust and modifiable to enable their application to a range of biological 
questions. To this end, the main aim of this thesis is to create methods to 
visualise and quantify the extent of peroxisome-ER contacts using two 
approaches: a split fluorescent protein reporter system and the proximity 
ligation assay, Duolink®. 
- In the split fluorescent protein reporter system, one half of a split 
fluorescent protein is targeted to the peroxisome membrane and the 
other half to the ER membrane. When the two organelles are in close 
apposition, the fluorescent halves should recombine, indicating contact 
between the organelles. To achieve this, two BiFC technologies will be 
used: dimerisation-dependent GFP and split superfolder GFP. 
- The second approach is to optimise the proximity ligation assay, 
Duolink®. This will be achieved by using peroxisome-ER contact site 
proteins as target proteins for the assay. Additionally, the assay will be 
conducted using an abundant peroxisomal membrane protein not known 
to be implicated in contact sites as a target. 
- Finally, both of these systems will be used to assess changes in the 
number of peroxisome-ER contacts following changes in physiological 
cellular conditions. 
It is hoped that the findings presented in this thesis will provide two novel 
methods to assess this newly discovered contact site and provide indication of 
the stimuli altering the extent of contact site formation. Ultimately, the systems 
presented here could be amended for the investigation of other peroxisome-
organelle contact sites to further our understanding of the important interplay 
between organelles. 
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Chapter 2: 
General materials and methods 
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2.1 Cell culture: 
Table 2.1. Cell lines used in this study 
Cell line Description Origin 
COS-7  African green monkey kidney 
cells 
ATCC: CRL-1651 
COS-7-GFP-SKL African green monkey kidney 
cells stably transfected with a 
construct encoding for a 
fusion protein of green 
fluorescent protein (GFP) 
carrying a consensus 
peroxisomal targeting signal 1 
(PTS1) of three amino acids 
(SKL; serine, lysine, leucine). 
This is sufficient to target GFP 
to peroxisomes in mammalian 
cells. 
Created from ATCC: 
CRL-1651 
G. Lüers, Univ. of 
Marburg, Germany 
(Koch et al., 2004) 
HeLa Human cervical 
adenocarcinoma epithelial 
cells. 
 
ATCC: CCL-2 
 
Cell culture maintenance: 
COS-7, COS-7-GFP-SKL and HeLa cells were cultured in DMEM (Dulbecco's 
Modified Eagle Medium) medium, high glucose (4.5 g/l) supplemented with 10% 
Fetal Bovine Serum (FBS), 100 U/ml penicillin, and 100 µg/ml streptomycin at 
37°C with 5% CO2 and 95% humidity. 
All cell lines were routinely cultured in supplemented DMEM medium. The 
medium was replaced as needed until cells reached confluency. Confluent cells 
were washed with 1x sterile phosphate-buffered saline (PBS) (pH 7.4) and 
detached from cell culture dishes using TrypLE Express Enzyme (1x), phenol-
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red free (Gibco, Thermo Fisher Scientific). The cells were harvested with 
supplemented DMEM medium and centrifuged at 1000rpm for 3 minutes at 
room temperature. The cell pellet was then resuspended in supplemented 
DMEM medium and plated onto cell culture dishes at the appropriate density. 
2.2 DEAE-dextran transfection: 
COS-7 and COS-7-GFP-SKL cells were grown on 19 mm glass coverslips in 6-
cm-diameter cell culture dishes and incubated overnight at 37°C with 5% CO2 
and 95% humidity. Cells were transfected using diethylaminoethyl (DEAE)-
dextran (Sigma-Aldrich). For transfections in a 6-cm-diameter cell culture dish, 
cells were transfected with 4 μg of DNA when using a single plasmid and 3.3 μg 
of DNA with transfected with two plasmids simultaneously. Cells were washed 
once with 1x sterile PBS (pH 7.4) and DEAE-dextran, DMEM with no 
supplements and DNA were added to cells. Cells were incubated at 37°C with 
5% CO2 and 95% humidity with shaking for 1.5 hours. Supplemented DMEM 
media containing 0.1% chloroquine was then added to cells for 3 hours to 
prevent lysosomal degradation of plasmids. Cells were then washed twice with 
1x sterile PBS and supplemented DMEM media was added to cells. Cells were 
incubated overnight at 37°C with 5% CO2 and 95% humidity. 
2.3 TurboFect transfection: 
HeLa cells were grown on 19 mm glass coverslips in 6-cm-diameter cell culture 
dishes and incubated overnight at 37°C with 5% CO2 and 95% humidity. Cells 
were transfected with TurboFect (Thermo Fisher Scientific) reagent. For 
transfections in a 6-cm-diameter cell culture dish, cells were transfected with 4 
μg of DNA when using a single plasmid and 3.3 μg of DNA with transfected with 
two plasmids simultaneously. Cells were washed once with 1x sterile PBS (pH 
7.4) and TurboFect, DMEM with no supplements and DNA were added to cells. 
Cells were incubated at 37°C with 5% CO2 and 95% humidity for 3 hours. Cells 
were then washed three times with 1x sterile PBS and supplemented DMEM 
media was added to cells. Cells were incubated overnight at 37°C with 5% CO2 
and 95% humidity. 
2.4 Immunofluorescence: 
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Cells grown on 19 mm glass coverslips washed with 1x PBS and fixed in 4% 
paraformaldehyde in PBS (pH 7.4) for 20 minutes at room temperature. Cells 
were then washed three times for 5 minutes with PBS. Cellular membranes 
were then permeabilised using 0.2% Triton X-100 for 10 minutes at room 
temperature. Cells were washed in PBS three times for 5 minutes and then 
blocked with 1% bovine serum albumin (BSA) for 10 minutes. Samples were 
then incubated with primary antibodies diluted to the appropriate dilutions in 1x 
PBS for 1 hour at room temperature. After washing three times for 5 minutes in 
PBS, samples were incubated with fluorescently labelled secondary antibodies 
for 1 hour at room temperature. To prepare the slides, coverslips were washed 
once in Milli-Q water and mounted in Mowiol 4-88 containing n-propyl gallate as 
an anti-fading reagent (3:1 mowiol with n-propyl gallate).  
2.5 Microscopy and image processing: 
Cell imaging was performed using an IX81 microscope (Olympus) equipped 
with an UPlanSApo 100×/1.40 oil objective (Olympus) and a CoolSNAP HQ2 
CCD camera. Digital images were taken and processed using VisiView software 
(Visitron Systems). Images were adjusted for contrast and brightness using 
MetaMorph 7 (Molecular Devices). 
2.6 Quantification of fluorescent signals: 
Quantification of fluorescent signals was performed using ImageJ software. 
Fluorescent signals from a minimum of 30 cells were quantified from each 
experimental repeat. In all cases, the cellular membrane was not defined, 
therefore, the number of fluorescent signals in close range to each visible 
nucleus was quantified. A custom macro was created for this purpose: 
• Outline the cell of interest using the freeform selection tool. 
• Edit -> Options -> Colors - Foreground white, background black. 
• Edit -> Clear Outside.  
• Image -> Type -> 8-bit.  
• Process -> Filters -> Gaussian Blur – Sigma 1. 
• Process -> Subtract Background – Rolling ball radius 20 pixels. 
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• Image -> Adjust -> Threshold – Manually threshold the image.  
• Process -> Binary -> Convert to Mask. 
• Process -> Binary -> Erode. 
• Process -> Binary -> Watershed.  
• Analyze -> Analyze Particles – Size 10-200, Circularity 0.10-1.00, Show 
Nothing. 
2.7 Statistical analysis:  
All statistical analysis was performed using GraphPad Prism Version 5 for 
Windows (GraphPad Software, La Jolla California USA). A two-tailed, unpaired t 
test was used to determine statistical differences against the indicated group (*, 
P < 0.05; **, P < 0.01; ***, P < 0.001). 
Table 2.2. Plasmids used in this study 
Plasmid Source 
Myc-VAPB C. Miller, King’s College 
London, London, UK 
FLAG-ACBD5 J. Costello, Univ. of 
Exeter, UK 
GFP-SKL S. Grille, Univ. of Exeter, 
UK 
Untargeted GFP1-10  
 
Gift from T. Cali, 
Universita degli studi Di 
Padova, Italy 
Kate-β11 Gift from T. Cali, 
Universita degli studi Di 
Padova, Italy 
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Table 2.3. Plasmids generated in this study 
Plasmid Enzymes Vector 
spGFP1-10-Pex26-
ALDP 
HindIII/XhoI pcDNA3.1 (+) 
spGFP1-10 HindIII/XhoI pcDNA3.1 (+) 
spGFP11x7 HindIII/XhoI pcDNA3.1 (+) 
 
Table 2.4. Primary and secondary antibodies used in this study 
Antibodies Type Dilution Source 
ACBD5 pcRb 1:100 Sigma-Aldrich 
VAPB mcMs 1:200 Proteintech  
PEX14 Rb 1:1400 D. Crane, Griffith 
University, 
Brisbane, 
Australia 
Myc pcRb 1:200 Abcam  
FLAG mcMs 1:500 Sigma-Aldrich  
Alexa Fluor 488 
IgG 
dk anti-rb 1:500 Molecular Probes 
Alexa Fluor 488 
IgG 
dk anti-ms 1:400 Molecular Probes 
Alexa Fluor 594 
IgG 
dk anti-rb 1:1000 Molecular Probes 
Alexa Fluor 594 
IgG 
dk anti-ms 1:1000 Molecular Probes 
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Chapter 3: 
Visualising peroxisome-endoplasmic reticulum contacts 
using the proximity ligation assay Duolink®. 
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3.1 Introduction: 
Cellular processes are governed by the dynamic interplay between proteins 
(Söderberg et al., 2006). The activity of such proteins is determined by their 
secondary modifications and their interacting partners (Söderberg et al., 2008). 
It is of growing importance to develop sensitive and specific techniques to 
visualise these endogenous proteins interactions to uncover their localisation 
and function. To this end, progress has been made in the development of 
biochemical methods such as co-immunoprecipitation (coIP) or fluorescence-
based methods such as bimolecular fluorescence complementation (BiFC) or 
fluorescence resonance energy transfer (FRET) (Bellucci et al., 2014). Though 
well-established, biochemical methods often fail to provide understanding of the 
cellular context of proteins (Bellucci et al., 2014) and many fluorescence-based 
methods are often associated with low sensitivity and brightness (Kerppola, 
2006). 
To overcome these limitations, the proximity ligation assay (PLA) was 
developed in 2002 by Fredriksson and colleagues (Fredriksson et al., 2002). 
This assay was first developed to allow in vitro detection of proteins. The first 
generation of PLA consisted of DNA aptamers, which are oligonucleotides 
specific to a target protein. When a pair of these aptamers binds the target 
protein, their free ends are brought in close proximity. This allows them to 
hybridise to a subsequently added connector oligonucleotide which allows 
ligation of the ends to take place. The ligation products are then replicated by 
nucleic acid amplification through polymerase chain reaction (PCR). The PCR 
products can then be detected and quantified which is indicative of the number 
of target protein molecules present in a sample (Fredriksson et al., 2002). This 
assay formed the basis of the in situ PLA which was developed by the same 
group in 2006 (Söderberg et al., 2006). This adaptation allows individual pairs of 
interacting proteins to be visualised and quantified in cell lines and fixed clinical 
samples using an antibody-based approach. This assay was commercialised in 
2007 under the name of “Duolink®” by Olink Bioscience, a biotechnology 
company founded by members of the group who pioneered PLA technology 
(Olink bioscience | AntibodyChain, 2009). Since 2015, Duolink® is now 
commercially available through Sigma-Aldrich. 
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Duolink® relies on the targeting of specific primary antibodies raised in two 
different species, such as mouse or rabbit, to two proteins of interest (Gullberg 
and Andersson, 2010). This is followed by the addition of proximity probes, 
which are oligonucleotides attached to secondary antibodies which are 
complementary to the primary antibodies. When the proteins of interest are in 
close proximity (<40 nm), this brings the oligonucleotides on the proximity 
probes close together so they can ligate with added “connector 
oligonucleotides” to form a circular DNA strand. This acts as a template for 
rolling circle amplification (RCA). Following RCA, the resulting DNA product, still 
covalently attached to the proximity probes, is detected through the addition of 
fluorescently-labelled probes. This allows single-molecule protein interaction 
events to be represented by discrete fluorescent signals which can be 
visualised and quantified with standard fluorescent microscopy methods 
(Söderberg et al., 2006).  
The use of this assay for the detection of protein-protein interactions has 
increased in recent years. This is, in part, due to the sensitivity and specificity of 
the method, allowing it to be used to detect single-molecule, and even transient, 
protein interactions (Söderberg et al., 2006). In addition, the ability to apply this 
assay to fixed cells and tissue samples offers significant advantage over other 
standardised methods for protein interaction studies, allowing endogenous 
interactions to be detected in situ (Bellucci et al., 2014). It is known that most 
organelles interact through inter-organellar tethering mediated by interacting 
proteins in sites called membrane contact sites (MCS) (Eisenberg-Bord et al., 
2016). Although these interactions are vital for normal cellular function, the 
mechanisms underlying the formation and function of MCSs remain to be fully 
elucidated. The lack of knowledge in this field is, perhaps, caused by a lack of 
appropriate tools (Eisenberg-Bord et al., 2016). Most assays to study these 
organelle interactions rely on over-expression of proteins to study contact sites 
in situ, which may alter the size or nature of MCSs or biochemical techniques 
which require denaturation of proteins, disrupting their native environment 
(Eisenberg-Bord et al., 2016). For these reasons, assays such as Duolink® 
have superseded previous techniques for further characterising the nature and 
role of MCSs. Perhaps the best studied MCSs are those between the 
mitochondria and the ER. These MCSs, known as mitochondria-associated ER 
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membranes (MAM), are essential for lipid and calcium homeostasis (Paillusson 
et al., 2016). The Duolink® assay has recently been optimised to study these 
interactions. 
As Duolink® is suitable for assessing protein interactions of less than 40 nm 
(Gullberg and Andersson, 2010), it was thought that this assay would be ideal 
for the study of MCSs as interacting proteins at MCSs are usually 10-40 nm 
apart (Eisenberg-Bord et al., 2016). Therefore, it was hypothesised that 
labelling a single membrane protein on each interacting organelle with a 
complementary primary antibody and followed by the Duolink® reagents, would 
allow events where the respective organelles were in close proximity to be 
visualised with a fluorescent readout (Tubbs et al., 2014). The first use of 
Duolink® in this way utilised putative interaction partners ER-resident protein 
VAPB and outer mitochondrial membrane protein, protein tyrosine 
phosphatase-interacting protein 51 (PTPIP51) as target proteins (De Vos et al., 
2012). This study used Duolink® as one of a few techniques to demonstrate 
that these two proteins interact to tether the respective organelles to regulate 
calcium homeostasis. This was shown by the formation of fluorescent signals 
after labelling both VAPB and PTPIP51 with complementary primary antibodies 
in fixed mammalian cells and performing the Duolink® assay (De Vos et al., 
2012). Duolink® has subsequently been used in many studies assessing 
mitochondria-ER associations, some of which used the outer mitochondrial 
membrane protein voltage-dependent anion channel (VDAC) and ER protein 
inositol 1,4,5-triphosphate receptor (IP3R) as target proteins (Hedskog et al., 
2013; Tubbs et al., 2014). These proteins are enriched at MAMs and are known 
to physically interact to facilitate Ca2+ transfer from the ER to mitochondria 
(Szabadkai et al., 2006). The use of Duolink® in these studies has enabled the 
identification of many roles in which this organelle association is involved. For 
example, in the pathogenesis of Alzheimer’s disease (Hedskog et al., 2013), 
amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) (Stoica et 
al., 2016), and also in hepatic insulin action and resistance (Tubbs et al., 2014). 
Following from the success of the use of Duolink® in investigating proximity 
between mitochondria and the ER, it was thought that this assay could also be 
applicable to the study of peroxisome-ER interactions (Fig 3.1). Little is known 
about the peroxisome-ER contact site size, however, electron microscopy data 
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suggests the size of these contact sites to be within the range that can be 
detected using the Duolink® assay (Costello et al., 2017a). In the case of 
peroxisome-ER contact sites, the only known tethering proteins are peroxisomal 
membrane proteins ACBD4 and ACBD5 and ER proteins VAPA and VAPB 
(Costello et al., 2017a; Costello et al., 2017b; Hua et al., 2017). It was, 
therefore, hypothesised that in events where peroxisomes and the ER were in 
close proximity, labelling ACBD4/5 and VAPA/B with complementary primary 
antibodies, followed by the Duolink® reagents, would allow ligation of the 
oligonucleotides on the proximity probes and RCA to take place. This would 
ultimately result in the formation of a fluorescent signal, indicating proximity 
between the two organelles (Fig 3.1). This assay would, again, offer the 
advantage of enabling visualisation of endogenous interactions within their 
cellular context. In addition, this assay could also be used to assess the effect 
of altering physiological cellular conditions on the integrity and number of 
peroxisome-ER contacts, shedding light on processes which are currently not 
well-understood. 
 
Fig. 3.1. Schematic illustration of Duolink® technology used to visualise 
proximity between peroxisomes and the ER using ACBD5 and VAPB as target 
proteins. 
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3.2 Materials and methods: 
3.2.1. Duolink® assay: 
COS-7 or COS-7-GFP-SKL cells were seeded onto 3.5-cm-diameter glass 
bottom dishes (Cellview; Greiner BioOne) and incubated overnight at 37°C with 
5% CO2 and 95% humidity. In some assays, cells were transfected after 24 
hours incubation using DEAE-dextran, following the same protocol as described 
in Section 2.2. In all assays, 48 hours after seeding, cells were fixed in 4% 
paraformaldehyde in PBS (pH 7.4) for 20 minutes at room temperature. Cellular 
membranes were permeabilised with 0.2% Triton X-100 for 10 minutes at room 
temperature and washed three times for 5 minutes in 1x PBS. The proximity 
ligation assay (PLA), Duolink® (Sigma-Aldrich), was then performed. 
Samples were blocked by adding Duolink® blocking solution and incubating for 
30 minutes at 37°C in a humidity chamber. The blocking solution was then 
removed and samples were incubated with primary antibodies diluted to the 
appropriate dilutions in antibody diluent supplied with the kit for 1 hour in a 
humidity chamber. Primary antibodies used are listed in Table 2.4. Samples 
were then washed twice for 5 minutes in 1x wash buffer A at room temperature. 
Samples were incubated with PLA probes (proximity probes) supplied in the kit, 
diluted 1:5 in antibody diluent, for 1 hour at 37°C in a humidity chamber. 
Samples were washed twice for 5 minutes in 1x wash buffer A at room 
temperature. PLA probes were ligated by incubating with ligase enzyme diluted 
1:40 in ligation buffer supplied with the kit for 30 minutes at 37°C in a humidity 
chamber. Samples were again washed in 1x wash buffer A at room temperature 
before incubation with polymerase enzyme diluted 1:80 in amplification buffer 
supplied with the kit for 100 minutes at 37°C in a humidity chamber. Following 
incubation, samples were washed twice for 10 minutes in 1x wash buffer B at 
room temperature and then washed once in 0.01x wash buffer B for 1 minute. 
19 mm coverslips were then mounted onto culture dishes using Mowiol 4-88 
(3:1 mowiol with n-propyl gallate) prior to imaging. Slides were then analysed 
with fluorescence microscopy as described in Section 2.5. Quantification of the 
fluorescent signals produced was performed as described in Section 2.6. 
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3.3 Results: 
3.3.1. ACBD5/VAPB-mediated peroxisome-ER proximity can be visualised 
using the proximity ligation assay, Duolink®: 
To optimise the Duolink® assay to visualise endogenous proximity between 
peroxisomes and the ER, the peroxisomal tethering protein ACBD5 and the ER 
tethering protein VAPB were used as target proteins for the assay. The primary 
antibody used against ACBD5 has been validated in COS-7 cells in a previous 
study by our group (Costello et al., 2017a) and the primary antibody against 
VAPB was validated by others in COS-7 cells to show specific binding to VAPB 
at the ER (Zhao et al., 2018). 
COS-7 cells stably expressing peroxisome-targeted GFP (GFP-SKL) (referred 
to as COS-7-GFP-SKL cells) were grown on glass-bottom dishes and fixed. 
This cell line was chosen to enable consistent labelling of peroxisomes to allow 
for assessment of whether the fluorescent signals produced from the Duolink® 
assay would co-localise with peroxisomes, confirming specificity of the assay. 
ACBD5 and VAPB were labelled with rabbit anti-ACBD5 and mouse anti-VAPB 
primary antibodies respectively. The Duolink® assay was then performed using 
mouse and rabbit secondary antibodies (proximity probes) complementary to 
the primary antibodies used. This resulted in the formation of red fluorescent 
signals, some of which are found in close proximity to peroxisomes. Controls 
were also performed to confirm specificity of the assay where the Duolink® 
assay was performed on fixed COS-7 cells but only one of each primary 
antibody or no primary antibody was used (Fig. 3.2). 
After performing the Duolink® assay, the slides were analysed with 
fluorescence microscopy and the number of fluorescent signals per cell 
(nucleus) were quantified in 30 cells. An average of 7.28 ± 1.20 fluorescent 
signals were formed per cell (nucleus). In the cases of the controls, cells had 
none or very few fluorescent signals. The average number of fluorescent 
signals for the anti-ACBD5 antibody alone was 0.4 ± 0.11. The average number 
of fluorescent signals produced when the anti-VAPB antibody was used alone 
was 0.37 ± 0.11 and when no primary antibody was used 0.57 ± 0.16 
fluorescent signals were produced (Fig. 3.5). 
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Fig. 3.2. Duolink® allows proximity between peroxisomes and the ER to be 
visualised by the formation of fluorescent signals. (A) Proximity between 
peroxisomes and the ER depicted as red fluorescent signals. (B) Peroxisomes 
labelled with GFP. (C) Overlay of red fluorescent signals from the Duolink® 
assay with labelled peroxisomes. (D) Zoom of (C), arrows indicate close 
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proximity of fluorescent signals with peroxisomes. (E-G) Negative controls using 
the Duolink® assay with anti-ACBD5 or anti-VAPB primary antibodies alone or 
no antibody. Arrows indicate a single fluorescent signal formed. Scale bars 
(main): 20µm (zoom): 2µm. 
3.3.2. An increase in peroxisome-ER association can be visualised using 
Duolink®: 
As indicated by previously published work from our group, overexpression of 
ACBD5 and VAPB increases contact between peroxisomes and the ER 
(Costello et al., 2017a). Therefore, it was hypothesised that the increase in 
association between the two organelles following overexpression of ACBD5 and 
VAPB would be visible by an increase in the number of fluorescent signals 
produced from the Duolink® assay. COS-7 cells were first transfected with a 
GFP-SKL plasmid to label peroxisomes. The cells were also transfected with 
Myc-tagged VAPB and FLAG-tagged ACBD5. Following fixation of the 
transfected cells the Duolink® assay was performed. First, the Myc and FLAG 
epitope tags were probed with rabbit anti-Myc and mouse anti-FLAG primary 
antibodies and the Duolink® assay was performed (Fig. 3.3). The Duolink® 
assay was then performed in the same way following overexpression of the 
tagged proteins but using primary antibodies against the ACBD5 and VAPB 
proteins (Fig. 3.4).  
Following analysis of the resulting slides it was found that overexpression of the 
tethering proteins dramatically increased the number of fluorescent signals 
produced using the Duolink® assay. When antibodies against the Myc and 
FLAG epitope tags were used, an average of 72.01 ± 5.52 fluorescent signals 
were formed per cell (nucleus) and when antibodies against the tethering 
proteins were used the number of fluorescent signals produced was 60.05 ± 
9.12 per cell (nucleus). Controls were also performed using the anti-Myc or anti-
FLAG primary antibodies individually on transfected cells to confirm specificity 
of the use of these antibodies with the Duolink® assay. In both cases, again, 
most cells had none or very few fluorescent signals. When the anti-Myc primary 
antibody was used alone an average of 0.1 ± 0.07 fluorescent signals were 
produced per cell (nucleus) and 0.37 ± 0.11 fluorescent signals were produced 
per cell (nucleus) when the anti-FLAG primary antibody was used alone. (Fig. 
3.5). 
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Fig. 3.3. An increase in peroxisome-ER associations can be visualised by 
an increase in fluorescent signals formed from the Duolink® assay using 
antibodies against epitope tags. (A) COS-7 cells transfected with GFP-SKL, 
Myc-VAPB and FLAG-ACBD5. The Duolink® assay was performed using the 
Myc and FLAG epitope tags as target proteins. Proximity between peroxisomes 
and the ER is depicted as red fluorescent signals. (B) Peroxisomes labelled with 
GFP-SKL. (C) Overlay of red fluorescent signals from the Duolink® assay with 
labelled peroxisomes. (D) Zoom of (C), arrows indicate close proximity of 
fluorescent signals with peroxisomes. (E-F) Negative controls using the 
Duolink® assay with anti-Myc or anti-FLAG primary antibodies alone. Arrows 
indicate a single fluorescent signal formed. Scale bars (main): 20µm (zoom): 
2µm. 
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Fig. 3.4. An increase in peroxisome-ER associations can be visualised by 
an increase in fluorescent signals formed from the Duolink® assay using 
antibodies against the tethering proteins. (A) COS-7 cells transfected with 
GFP-SKL, Myc-VAPB and FLAG-ACBD5. The Duolink® assay was performed 
using ACBD5 and VAPB as target proteins. Proximity between peroxisomes 
and the ER is depicted as red fluorescent signals. (B) Peroxisomes labelled with 
GFP-SKL. (C) Overlay of red fluorescent signals from the Duolink® assay with 
labelled peroxisomes. (D) Zoom of (C), arrows indicate close proximity of 
fluorescent signals with peroxisomes. Scale bars (main): 20µm (zoom): 2µm.  
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Fig. 3.5. Quantitative analysis of the number of red fluorescent signals produced 
per cell (nucleus) following the use of the Duolink® assay to measure 
endogenous proximity between peroxisomes and the ER and proximity 
following overexpression of ACBD5 and VAPB. The number of red fluorescent 
signals produced per cell (nucleus) following the use of each primary antibody 
alone is shown. Data are presented as mean ± standard error of the mean 
(SEM). Data were analysed with a two-tailed, unpaired t test (ns, not significant, 
**, P < 0.01; ***, P < 0.001). n = 30 cells. Data shown are the result of three 
independent experiments. 
3.3.3. Duolink® can be used to visualise proximity between peroxisomes 
and the ER using target proteins not known to be involved in inter-
organelle tethering: 
Following the success of using ACBD5 and VAPB as target proteins for the 
Duolink® assay, it was decided to assess whether other ubiquitous peroxisomal 
membrane proteins can be used as target proteins for the assay. VAPB was still 
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used as a target for the ER membrane, however, in this case, the peroxisomal 
membrane protein PEX14 was used as the peroxisomal target. PEX14 is a key 
component of the peroxisomal import machinery, acting as a docking factor for 
the PTS1 receptor, PEX5 (Fransen et al., 1998). The PEX14 antibody used was 
made and validated in a previous study (Nguyen et al., 2006). 
COS-7-GFP-SKL cells were grown and fixed and the Duolink® assay was 
performed as described in Section 3.2.1 but the peroxisomal membrane was 
targeted with rabbit anti-PEX14 primary antibody and the ER membrane with 
mouse anti-VAPB primary antibody as previously. Controls were also performed 
using the anti-PEX14 or anti-VAPB antibody individually (Fig. 3.6). Analysis of 
the resulting slides showed that an average of 14.18 ± 1.81 fluorescent signals 
were formed per cell (nucleus) when the anti-PEX14 and anti-VAPB antibodies 
were used together. This is significantly higher than the number of fluorescent 
signals produced when ACBD5 and VAPB were used as target proteins 
(P≤0.001).  When the anti-VAPB primary antibody was used alone, an average 
of 0.37 ± 0.11 fluorescent signals were formed per cell (nucleus) and when the 
anti-PEX14 primary antibody was used alone, an average of 0.57 ± 0.12 
fluorescent signals were formed per cell (nucleus) (Fig. 3.6). 
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Fig. 3.6. – Proximity between peroxisomes and the ER can be visualised 
by Duolink® using PEX14 and VAPB as targets. (A) Proximity between 
peroxisomes and the ER depicted as red fluorescent signals. (B) Peroxisomes 
labelled with GFP-SKL. (C) Overlay of red fluorescent signals from the Duolink® 
assay with labelled peroxisomes. (D) Zoom of (C), arrows indicate close 
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proximity of fluorescent signals with peroxisomes. (E-F) Negative control using 
the Duolink® assay with anti-VAPB or anti-PEX14 primary antibody alone. 
Arrows indicate fluorescent signals formed. Scale bars (main): 20µm (zoom): 
2µm. (G) Quantitative analysis of the number of red fluorescent signals 
produced following use of anti-VAPB and anti-PEX14 antibodies as targets. The 
number of red fluorescent signals produced following the use of each primary 
antibody alone is also shown (H) A quantitative comparison of the number of 
fluorescent signals produced using the Duolink® assay to assess peroxisome-
ER interactions using either VAPB and ACBD5 or VAPB and PEX14 as targets. 
Data are presented as mean ± SEM. Data were analysed with a two-tailed, 
unpaired t test (***, P < 0.001). n = 30 cells. Data shown are the result of three 
independent experiments. 
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3.4 Discussion: 
It is now recognised that cellular organelles cooperate extensively in order to 
carry out their essential functions. However, our understanding of these sites, 
thus far, has been hampered by a lack of effective tools. The growing 
understanding of peroxisome-organelle contact sites and the relevance of these 
sites in health and disease, has led to a further push to develop robust and 
reliable methods to enable their study. The results presented here show that the 
in situ PLA, Duolink®, is an effective method to visualise and quantify proximity 
between these organelles. This study is, to date, the first to utilise this method 
to visualise peroxisome-ER contact sites in mammalian cells.  
Employing Duolink® for the study of inter-organelle contact sites raises several 
significant advantages. Primarily, Duolink® is an incredibly simple tool which 
does not require any specialist expertise, unlike other techniques such as EM. 
Any laboratory group which frequently performs immunofluorescence 
experiments will be capable to carry out the Duolink® assay with their existing 
knowledge and equipment. The only specialised equipment required for the 
assay is a heat transfer block or incubator which can be heated to 37°C to 
enable a few of the steps in the assay to be carried out efficiently. However, 
both of these are standard equipment in most laboratories, particularly if 
Duolink® is performed on fixed cell samples as maintenance of the cell lines 
used will require an incubator. Additionally, unlike many other commonly used 
techniques to study protein interactions, Duolink® (when used to monitor 
endogenous protein interactions) does not require any molecular cloning, which 
can be complicated and time-consuming. 
One of the greatest strengths of the Duolink® assay is its unparalleled 
sensitivity and brightness. Weak, or even transient, single molecule interaction 
events are labelled by one RCA product which is visible as a robust and bright 
signal due to the exponential nature of DNA amplification. This allows high 
visibility of the signals over any background fluorescence in a fluorescence 
microscope. Additionally, the sensitivity can be increased by altering the 
amplification conditions, for example, by increasing incubation time for 
amplification (Weibrecht et al., 2010). Moreover, since the binding of two 
different primary antibodies is required for a signal to be produced, the risk of 
unspecific binding events is significantly minimised (Leuchowius et al., 2009). 
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As Duolink® is an in situ assay, it also hosts the advantage of allowing protein 
interaction events to be monitored within their native cellular environment, 
avoiding the need for cell lysis, as is required for many biochemical assays and 
also avoids the occurrence of artifacts caused by protein overexpression or 
ectopic expression (Söderberg et al., 2006). As protein expression is not 
required, this also means that the assay can be carried out in fixed clinical 
samples, raising a significant advantage over many other methods used to 
study protein interactions such as FRET and BiFC (Leuchowius et al., 2009). 
The results presented in this study show that Duolink® is an effective method to 
study peroxisome-ER associations. The use of Duolink® in this context led to 
the formation of discrete fluorescent signals in areas where the target proteins, 
ACBD5 and VAPB were in close proximity (Fig. 3.2). These could be easily 
visualised and quantified using fluorescence microscopy providing an indication 
of the frequency of contacts between peroxisomes and the ER. In addition, the 
fluorescent signals produced were found in close proximity to peroxisomes, 
suggesting that these signals indicate peroxisomal interactions (Fig. 3.2). An 
increase in the number of sites of contact between peroxisomes and the ER, 
following overexpression of ACBD5 and VAPB was shown by an increase in the 
number of fluorescent signals produced (Fig. 3.3, Fig. 3.4). When using 
antibodies against the epitope tags on the expressed proteins, the number of 
fluorescent signals increased 10-fold compared to no protein expression 
(P≤0.001) (Fig. 3.5). Using antibodies against ACBD5 and VAPB following 
overexpression showed about an 8.5-fold increase compared to no protein 
expression (P≤0.001) (Fig. 3.5). This result is consistent with previously 
reported EM data showing that the number of peroxisome-ER contacts 
increases when the tethering proteins are overexpressed (Costello et al., 
2017a). This result is also comparable to data obtained in a similar study 
investigating mitochondria-ER associations when a protein known to increase 
these associations was overexpressed (Tubbs et al., 2014). Slightly less 
fluorescent signals (~10 per nucleus) were produced on average when using 
antibodies against the tethering proteins compared to using antibodies against 
the epitope tags following overexpression (Fig. 3.5). Although non-significant, 
the discrepancy between these results is interesting. It can be assumed that this 
difference is because the antibodies against the epitope tags are more specific, 
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especially considering that these antibodies are more widely used and are 
better established than those against the tethering proteins, therefore, they may 
label their target proteins more efficiently. It is also possible that the epitope 
tags may be more accessible than the tethering proteins in the contact site. 
When each of the antibodies was used individually with the Duolink® system, or 
no antibody was used at all, none or very few signals were present in cells (Fig 
3.5). This has also been observed through using this system to investigate 
mitochondria-ER interactions (Gomez-Suaga et al., 2017). It is not specifically 
known why this occurs, however, it is possible that this could be caused by non-
specific association of the added proximity probes resulting in RCA and a 
fluorescent product. 
It was also shown in this study that proximity between peroxisomes and the ER 
can also be assessed by using proteins which are not known to be involved in 
contact sites as target proteins. In this case, the abundant peroxisomal 
membrane protein PEX14 was used. The number of fluorescent signals 
produced using PEX14 as a target protein was approximately double the 
number using ACBD5 as a target protein with VAPB (P≤0.001) (Fig. 3.6). 
PEX14 has never been reported to physically interact with VAPB, which 
suggests that Duolink® is capable of reporting physical proximity of proteins, as 
well as protein interactions. So as long as the target proteins are within a 
distance of ≤40 nm, a fluorescent signal should be produced using the Duolink® 
system. This finding can be used to our advantage as this means that we are 
now capable of using a variety of abundant organelle membrane proteins to 
study organelle interactions, provided that 1) the chosen membrane proteins 
are localised at the interface at which the two organelles interact; 2) they reside 
within a distance of ≤40 nm when the two organelles interact; and 3) specific 
antibodies against the proteins are available. Using these proteins as target 
proteins is advantageous as will enable future studies to be conducted in which 
the known tethering proteins are silenced or knocked out using genome editing 
strategies. This will aid in uncovering the physiological roles of tethering 
proteins through observing the effect of their absence. Moreover, this will also 
enable patient cell conditions to be emulated, for example, the effect of the lack 
of function of ACBD5 could be observed. This would obviously not be possible if 
the assay relied on targeting the tethering proteins of interest. In addition, this 
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also means that previous knowledge of the tethering proteins is not necessary 
in order to study organelle interactions with this system. 
Despite the clear advantages of this finding, it also means that results using this 
assay should be analysed cautiously. The formation of fluorescent signals using 
the Duolink® assay may solely indicate proximity between the two target 
proteins, not a genuine interaction. Therefore, this system should not be used 
exclusively to test for an interaction between two putative interacting partners, 
instead, it should be combined with other methods to confirm a genuine 
interaction. 
Although Duolink® is a simple and effective system to study organelle 
interactions, it does harbour some limitations. The main drawback of Duolink® 
is the cost. The cost of the entire Duolink® starter kit from Sigma-Aldrich is over 
£600 for 30 reactions (as of September 2018) (Duolink® PLA Technology - 
Protein Interaction | Sigma-Aldrich, 2017). This, combined with the high cost of 
primary antibodies also required for the assay, renders Duolink® a very 
expensive method which may not be feasible for all laboratory groups. Despite 
this, it is possible to make some of the reagents required for the assay in-house, 
such as the wash buffers and the recipes for these have been published 
(Mendez and Banerjee, 2017). Sigma-Aldrich also sell a PLA “Probemaker” kit 
which allows the user to create their own PLA probes using antibodies of their 
choice (Duolink® PLA Technology - Protein Interaction | Sigma-Aldrich, 2017). 
Employing both of these alternatives could help to significantly reduce the cost 
of the assay long-term. Another limitation of Duolink® is that the samples need 
to be fixed, similarly to other immunofluorescence methods. This means that the 
dynamic nature of contact site formation cannot be assessed.  
Despite the ease of use of the Duolink® system, it should be noted that there 
are many steps required for the assay. If these are all carried out correctly, at 
the recommended temperatures and times, the assay should produce reliable 
results. However, if this is not the case, it will affect the results obtained. The 
number of incubation steps and wash steps required for this assay also 
increases the risk of losing cells at each step, however, the assay can also be 
performed in a 96-well plate format allowing several reactions to be performed 
simultaneously to maintain a high throughput (Leuchowius et al., 2009). The 
efficacy of the Duolink® assay is also dependent on the availability of 
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appropriate antibodies, in many cases, well-established antibodies against the 
target proteins may not be available. Moreover, Duolink® requires antibodies 
from two different species to be used, in the case of this study, mouse and 
rabbit antibodies were required, but other species combinations are offered with 
the Duolink® starter kits. In some cases, it may not be possible to obtain the 
required antibodies from the two different species specified in the starter kits, 
however, this could be rectified by customising complementary PLA probes. As 
demonstrated in this study, it may also be possible to use other abundant 
organelle membrane proteins as target proteins if the desired antibodies are not 
available. 
An interesting observation in this study was that the number of fluorescent 
signals produced when using the Duolink® assay to study endogenous 
peroxisome-ER interactions (with no protein expression and ACBD5 and VAPB 
primary antibodies) was much lower than the number of contact sites observed 
between the organelles using EM. In EM, it has been observed that 
approximately 65-70% of peroxisomes in COS-7 cells are in contact with the ER 
at a given time (Costello et al., 2017a), however, using the Duolink® assay, an 
average of just 7 fluorescent signals are formed under the same conditions. It 
can be seen in Figure 3.2 that the average number of fluorescent signals is not 
close to this percentage considering the number of peroxisomes in the cell. This 
result was obtained in every cell and every repeat of the experiment. It has 
been assumed in the past, that the number of fluorescent signals produced in 
this assay should be proportional to the number of protein associations in the 
cell (Mocanu et al., 2011), however, this result suggests that this is not the 
case. Moreover, similar discrepancies have also been reported in another study 
(Leuchowius et al., 2009). This prompted a full comparative analysis of the 
Duolink® system with FRET (Mocanu et al., 2011). Through this, it was 
suggested that the number of fluorescent signals formed using this system can 
become “saturated” at medium to high expression levels of the proteins of 
interest. At this point, no more signals are formed despite subsequent protein 
interactions that are shown to occur through the use of FRET. It was 
hypothesised in this study that the saturation phenomenon is due to steric 
hindrance between densely packed proximity probes which might prevent 
enzymes from taking part in the amplification process. Therefore, the Duolink® 
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assay only detects a fraction of the interacting molecules as it depends on both 
molecular proximities and also the equilibrium of association/dissociation 
reactions and enzymatic processes. It should be noted, however, that in this 
investigation it was suggested that saturation occurs when the proteins reach 
an expression level of about 1–2 million molecules/cell (Mocanu et al., 2011). 
This is likely much higher than the expression level of the proteins investigated 
in the present study. Therefore, the reason for the comparatively low number of 
fluorescent signals is not fully understood, however, it is clear that the Duolink® 
reaction is incredibly complex and will require full molecular analysis in order to 
completely understand this phenomenon. For this reason, it can be suggested 
that Duolink® should be considered a semi-quantitative tool for measuring 
protein associations. 
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Chapter 4:  
Visualising peroxisome-endoplasmic reticulum contact sites 
using fluorescent reporter systems. 
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4.1 Introduction: 
The prevailing question we face in the postgenomic era is how to characterise 
the roles of ~20,000 proteins encoded in the human genome. To this end, 
progress has been made in devising methods to tag proteins to uncover their 
function. This includes the use of peptides such as epitope tags, which have no 
function individually, but can be recognised by other expressed proteins 
(Kamiyama et al., 2016), or fluorescent proteins, such as green fluorescent 
protein (GFP). GFP was first discovered in 1962 by Shimomura and colleagues 
as a companion protein to aequorin, the chemiluminescent protein from 
Aequorea jellyfish (Shimomura et al., 1962). Since the discovery of these 
proteins, they have been used extensively in proteomic studies to track the 
localisation of putative proteins (through fluorescence-based methods) and gain 
insight into their interacting partners (using epitope tags and 
immunoprecipitation) (Leonetti et al., 2016). Following the success of the use of 
GFP, it was hypothesised that the use of this protein could be extended to in 
vivo protein-protein interaction studies. The first advancement in this direction 
was the advent of bimolecular fluorescence complementation (BiFC) assays. 
This began with the creation of a split GFP molecule whose reassembly could 
be directed by antiparallel leucine zippers (Ghosh et al., 2000). When dissected 
between amino acids 157 and 158, both halves of GFP are non-fluorescent and 
it is only when they recombine, following heterodimerisation of the leucine 
zippers attached to each half, that fluorescence can be restored. Unfortunately, 
this system harboured the disadvantage of expressing very large halves of 
GFP, which may interfere with the biological system of interest and resulted in 
poor re-folding of GFP (Ghosh et al., 2000). 
In order to expand the range of split fluorescent protein technologies and 
overcome some of the issues associated with previous attempts, several new 
systems have been created. This includes split Venus BiFC assays which are 
the most widely used for testing protein interactions under physiological 
conditions (Miller et al., 2015). Venus is a yellow fluorescent protein (YFP) 
variant carrying a F46L mutation which allows for faster chromophore 
maturation (Nagai et al., 2002). Several split Venus variants have been made 
and successfully used for the in vivo study of protein-protein interactions (Shyu 
et al., 2006; Ohashi and Mizuno, 2014). Furthermore, a dimerisation-dependent 
69 
 
fluorescent protein (ddFP) variant was created in 2012 by Alford and colleagues 
(Alford et al., 2012b). This technology involves the reversible binding of two 
“dark” fluorescent protein monomers which can recombine to form a fluorescent 
heterodimeric complex (Alford et al., 2012a) (Fig. 4.1). The first generation 
construct was a dimerisation-dependent red fluorescent protein (RFP), which 
proved to be effective in many biosensing applications, but had limited 
brightness and contrast (Alford et al., 2012b). To improve this system, efforts 
were made to expand the colour palette of ddFPs and improve their brightness 
and contrast. Through a process of site-directed mutagenesis of the original 
ddRFP construct followed by rounds of directed evolution and gene shuffling, 
dimerisation-dependent GFP (ddGFP) was created (Alford et al., 2012a). This 
variant was greatly improved in terms of brightness and contrast and also 
displayed a much lower dissociation constant, making it ideal for use as a 
reversible reporter of protein-protein interactions. In the same way as ddRFP, 
ddGFP can be split into two monomers, designated “ddGFP-A” and “ddGFP-B”. 
The ddGFP-A half contains the preformed, but quenched, chromophore, 
whereas the ddGFP-B half lacks a chromophore. It is only when these two 
halves recombine that fluorescence is restored (Alford et al., 2012a). This 
feature suggested that ddFPs could be useful for visualising organelle contact 
sites. It was thought that if one half of the ddFP was targeted to the surface of 
one organelle, and the other half to the surface of an interacting organelle, then 
fluorescence would only be restored when the respective organelles were in 
close proximity, allowing the two halves of the ddFP to recombine. 
 
Fig. 4.1. Schematic illustration of the ddFP technology. (From: Alford et al., 
2012a) 
In this way, the ddGFP system was first used to assess mitochondria-ER 
contact sites. The ddGFP-A half was targeted to the ER via fusion to the C-
terminus of the ER protein calnexin and the ddGFP-B half was targeted to 
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mitochondria via fusion to the C-terminus of mitochondrial protein translocase of 
outer membrane-20 (Tom20) (Alford et al., 2012a). When co-expressed in HeLa 
cells, bright green fluorescence was observed in the perinuclear region of the 
cells, indicating that the mitochondria and ER were in close proximity. No 
fluorescence was observed when the constructs were expressed individually. It 
was thought that this system could also be applied to investigating peroxisome-
ER contact sites. To achieve this, we created a peroxisome-targeted ddGFP-B 
construct (Fig. 4.2). This construct was targeted to peroxisomes via the 
transmembrane domain and tail (TMD-T) region of the peroxisomal contact site 
protein ACBD5 (amino acids 503-534) (Fig. 4.2.). This was previously found to 
target specifically to peroxisomes through binding to the peroxisomal import 
receptor PEX19 (Costello et al., 2017c). This sequence was connected to a 10 
amino acid linker and fused to the C-terminus of ddGFP-B. A FLAG epitope tag 
was also fused to the N-terminus of ddGFP-B to allow for tracking of the 
subcellular localisation of the construct following transfection into mammalian 
cells using immuno-staining methods (Fig. 4.2). As the ER has been shown to 
‘wrap around’ peroxisomes (Novikoff and Novikoff, 1972; Zaar et al., 1987; 
Grabenbauer et al., 2000) it was thought that the calnexin-targeted ddGFP-A 
half, localised to the cytosolic face of the ER, should be in an appropriate 
location to contact the peroxisome-targeted ddGFP-B half and heterodimerise 
when the organelles are in close proximity, thereafter producing a fluorescent 
signal (Fig. 4.2). 
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Fig. 4.2. (A) Schematic illustration of the targeting of the ddGFP fragments to 
the peroxisomal and ER membranes to visualise peroxisome-ER contact sites. 
The fragments recombine when the organelles are in close proximity, producing 
a fluorescent signal. (B) Schematic illustration of the peroxisome-targeted 
ddGFP-B half. (C) Schematic illustration of the ER-targeted ddGFP-A half. 
For the analysis of peroxisome-ER contact sites, both the peroxisome and ER-
targeted ddGFP constructs were first transfected into COS-7 cells and the cells 
were subsequently fixed prior to analysis with fluorescence microscopy. 
Following analysis, it was found that no fluorescent signal could be observed, 
only natural autofluorescence of the cells was visible (Fig. 4.3). In order to 
ascertain that the peroxisome-targeted construct was correctly localised 
following transfection, transfected cells were immuno-stained in order to detect 
the localisation of the FLAG epitope tag. This showed that the construct 
targeted correctly to peroxisomes (Fig. 4.3). The same could not be confirmed 
for the ER-targeted construct due to the absence of an epitope tag. HeLa cells 
were subsequently transfected with both constructs, consistent with the 
previous literature, and cells were either fixed or analysed via live cell imaging. 
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In both cases, no fluorescent signal was observed above the autofluorescence 
of the cells (Fig. 4.3). It is possible that the lack of fluorescent signal observed 
was due to the recombined fluorescent signal displaying low brightness (Alford 
et al., 2012a). This system consequently has not been used extensively in the 
field. 
 
Fig. 4.3. The ddGFP signal is not bright enough to be seen over 
autofluorescence. (A) ER-targeted ddGFP-A and peroxisome-targeted 
ddGFP-B expressed in COS-7 cells. Only autofluorescence of the cells can be 
seen. (B) ER-targeted ddGFP-A and peroxisome-targeted ddGFP-B expressed 
in HeLa cells. Only autofluorescence of the cells can be seen. (C-D) 
Peroxisome-targeted ddGFP-B expressed in COS-7 cells and immuno-stained 
with anti-FLAG antibody. No fluorescence seen at 488 nm (C). Punctate red 
fluorescent structures can be seen at 594 nm, indicating correct targeting of 
ddGFP-B to peroxisomes. Scale bars: 20µm. 
To overcome the issues observed with the use of ddFP systems, a new split 
GFP system was used. This system was created by Cabantous and colleagues 
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(Cabantous et al., 2005) and consists of soluble fragments of ‘superfolder’ GFP 
which can self-associated without the assistance of other protein-protein 
interactions. Superfolder GFP is a variant of GFP which was created following 
the observation that GFP is prone to misfolding when expressed as fusions with 
other proteins (Tsien, 1998). This robustly folded version of GFP was created 
from a previous variant of GFP which was optimised for folding called ‘folding 
reporter GFP’. Folding reporter GFP contains the ‘cycle-3’ mutations (F99S, 
M153T, V163A (Crameri et al., 1996), F64L and S65T (Patterson et al., 1997)). 
Superfolder GFP contains the folding reporter GFP mutations and six new 
mutations (S30R, Y39N, N105T, Y145F, I171V and A206V), creating a variant 
of GFP which displays enhanced folding and higher fluorescence when 
expressed as a protein fusion (Pédelacq et al., 2006). 
In order to create a split version of this protein to assess protein-protein 
interactions, the superfolder GFP molecule is split between the tenth and 
eleventh β-strand, creating two fragments; GFP1-10 (amino acids 1-214) and 
GFP11 (amino acids 214-230) (Fig. 4.4). GFP1-10 is non-fluorescent 
individually but contains the three residues that constitute the GFP 
chromophore (Kamiyama et al., 2016). Fluorescence can only be produced 
following maturation of the chromophore which requires the conserved E222 
residue on GFP11 (Barondeau et al., 2003) (Fig. 4.4). This split system has 
been successfully used for many different applications, such as protein 
quantification (Cabantous et al., 2005), protein localisation studies (Kaddoum et 
al., 2010; Van Engelenburg and Palmer, 2010; Hyun et al., 2015) and cell-cell 
contact detection (Feinberg et al., 2008). More recently, this split superfolder 
GFP (spGFP) system has been used to study contact sites between 
mitochondria and the ER in mammalian cells (Cieri et al., 2018; Kakimoto et al., 
2018; Yang et al., 2018). All of these studies capitalised on the idea that if one 
fragment of split GFP was targeted to one organelle membrane and the other 
fragment targeted to the opposing membrane, then the two fragments would 
only recombine and produce fluorescence if the organelles were in close 
proximity, thereby providing an indication of contact site formation.  
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Fig. 4.4. Schematic illustration of spGFP technology. (From: Kamiyama et al., 
2016) 
Following the success of the use of spGFP technology in assessing 
mitochondria-ER contact sites, it was hypothesised that this system could also 
be used to assess similar peroxisome-ER contact sites. In this case, it was 
reasoned that if the GFP1-10 portion of spGFP was targeted to the peroxisomal 
membrane and the GFP β-strand 11 to the ER membrane, then fluorescence 
would only be restored if the two organelles were in close proximity (Fig. 4.5). 
 
Fig. 4.5. Schematic illustration of the targeting of the spGFP fragments to the 
peroxisomal and ER membranes to visualise peroxisome-ER contact sites. The 
fragments recombine when the organelles are in close proximity, producing a 
fluorescent signal. 
To target the GFP1-10 and 11 fragments to the peroxisome and ER membrane, 
the targeting sequences used in both cases were small in size. This ensured 
that only the closest associations of the membranes would be detected. In 
addition, a restriction enzyme site was place before the targeting sequence in 
all cases to allow the targeting sequence to be modified for future studies. The 
GFP1-10 fragment was targeted to peroxisomes using a PEX26-ALDP chimera 
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protein (Fig. 4.6). PEX26 is a tail anchored protein of the peroxisomal 
membrane which is targeted to peroxisomes via PEX19, an import receptor for 
most peroxisomal membrane proteins (Halbach et al., 2006). The C-terminal 
targeting signal of PEX26 contains two binding sites for PEX19, one in the 
transmembrane domain (TMD) of the protein and the other in the luminal 
domain, the latter being more important for correct targeting of the protein to 
peroxisomes with no mitochondrial mistargeting (Halbach et al., 2006). The 
adrenoleukodystrophy protein, ALDP, is another peroxisomal membrane protein 
that is a member of the ATP-binding cassette transporter protein family (Gärtner 
et al., 2002). Previous literature showed that expression of a fusion of the 
luminal PEX19-binding site of PEX26 (amino acids 2-274) with a fragment of 
the membrane protein-targeting signal of ALDP (amino acids 87-164) led to 
complete peroxisomal localisation (Halbach et al., 2006; Castro et al., 2018a). 
Therefore, it was hypothesised that this would provide robust peroxisomal 
targeting of the GFP1-10 fragment. This sequence was fused to the C-terminus 
of the GFP1-10 sequence to create a targeted spGFP construct. This construct 
will henceforth be referred to as spGFP1-10-Pex26-ALDP (Fig. 4.6).  
A second peroxisome-targeted GFP1-10 construct was also created. This 
construct was targeted to peroxisomes via the TMD and tail (TMD-T) region of 
the peroxisomal contact site protein ACBD5 (amino acids 503-534) (Fig. 4.6). 
This was previously found to target specifically to peroxisomes through binding 
to the peroxisomal import receptor PEX19 (Costello et al., 2017c). This was 
fused to the C-terminus of the GFP1-10 sequence. This construct will be 
referred to as spGFP1-10 (Fig. 4.6). 
The GFP11 fragment was targeted to the ER via the TMD-T region of ER 
membrane protein VAPB (amino acids 223-243) (Fig. 4.6). This targeting 
sequence was chosen as recent work using a split-Venus fluorescent reporter 
system to study interactions between mitochondria and the ER showed that this 
sequence is sufficient to target proteins to the cytoplasmic face of the ER 
membrane (Harmon et al., 2017). Due to the small size of the GFP11 fragment, 
it can be arranged into tandem arrays in order to amplify the fluorescent signal 
(Kamiyama et al., 2016); this helps in reducing issues such as low fluorescence 
intensity or photobleaching that can often occur with fluorescence imaging. 
According to previously published literature, seven copies of the GFP11 
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fragment with a 15 amino acid linker length between the repeats produced the 
highest fluorescent signal (Kamiyama et al., 2016). Synonymous codons were 
used in the tandem arrays in order to avoid deleterious recombination during 
cloning which can be caused by repetitive nucleic acid sequences (Kamiyama 
et al., 2016). This construct will be referred to as spGFP11x7 (Fig. 4.6). 
 
Fig. 4.6. Schematic illustration of the spGFP constructs created in this study. (A) 
Pex26-ALDP-targeted GFP1-10. (B) ACBD5 TMD-T-targeted GFP1-10. (C) 
VAPB-TMD-T-targeted GFP11. 
The GFP1-10 and 11 sequences were obtained from previously published 
literature (Kamiyama et al., 2016). A 17 amino acid linker 
(GTGGGGSGTGGGGSGGG) was inserted between GFP1-10/11 fragment and 
the targeting sequence in all cases. A FLAG epitope tag was fused to the N-
terminus of the GFP1-10 constructs and a Myc epitope tag was fused to the N-
terminus of the GFP11 construct to allow for tracking of the subcellular 
localisation of the construct following transfection into mammalian cells.  
The overall size of the recombined targeted spGFP constructs was also 
considered. As the average distance between organelle membranes at contact 
sites is between 10-40 nm (Eisenberg-Bord et al., 2016), the overall size of the 
recombined constructs would need to be ~100 amino acids. This is because 
unstructured peptide chains can extend up to 0.38nm per residue (Pillardy et 
al., 2001). The linker length of each of the constructs created, combined with 
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the size of the spGFP fragments should be sufficient to span this contact site 
without disrupting endogenous organelle associations. 
This system should allow peroxisome-ER contact sites to be easily visualised 
and quantified. This will allow further understanding and characterisation of 
contacts between these organelles, and ultimately contacts between 
peroxisomes and other organelles.  
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4.2 Materials and methods: 
4.2.1. Molecular cloning: 
Specific details of the design of the spGFP constructs can be found in Section 
4.1. The sequences used are listed in Table 4.1. Gene synthesis was performed 
by Eurofins (Eurofins Genomics, Ebersberg, Germany). The resulting construct 
was transformed into the transient host DH5α competent Escherichia coli cells 
(Thermo Fisher Scientific). DNA was extracted through minipreparation using 
the NucleoSpin plasmid kit (Macherey-Nagel). The resulting DNA was ligated 
into a pcDNA3.1 (+) vector using restriction enzymes HindIII and XhoI. Correctly 
ligated DNA was obtained through agarose gel electrophoresis and gel 
extraction. Ligated plasmids were transformed into XL-10 Gold ultracompetent 
E. coli cells (Agilent Technologies) and DNA was extracted through 
midipreparation using the NucleoSpin plasmid kit (Macherey-Nagel).  
Table 4.1. Sequences used to design spGFP constructs 
Name Sequence  
GFP1-10  
(From: 
Kamiyama et 
al., 2016) 
ATGTCCAAAGGAGAAGAACTGTTTACCGGTGTTGTGCCAA
TTTTGGTTGAACTCGATGGTGATGTCAACGGACATAAGTT
CTCAGTGAGAGGCGAAGGAGAAGGTGACGCCACCATTGG
AAAATTGACTCTTAAATTCATCTGTACTACTGGTAAACTTC
CTGTACCATGGCCGACTCTCGTAACAACGCTTACGTACGG
AGTTCAGTGCTTTTCGAGATACCCAGACCATATGAAAAGA
CATGACTTTTTTAAGTCGGCTATGCCTGAAGGTTACGTGC
AAGAAAGAACAATTTCGTTCAAAGATGATGGAAAATATAAA
ACTAGAGCAGTTGTTAAATTTGAAGGAGATACTTTGGTTAA
CCGCATTGAACTGAAAGGAACAGATTTTAAAGAAGATGGT
AATATTCTTGGACACAAACTCGAATACAATTTTAATAGTCAT
AACGTATACATCACTGCTGAAAGCAAAAGAACGGAATTAA
AGCGAATTTCACAGTACGCCATAATGTAGAAGATGGCAGT
GTTCAACTTGCCGACCATTACCAACAAAACACCCCTATTG
GAGACGGTCCGGTACTTCTTCCTGATAATCACTACCTCTC
AACACAAACAGTCCTGAGCAAAGATCCAAATGAAAAA 
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GFP11x7 
(From: 
Kamiyama et 
al., 2016) 
ATGCGTGACCACATGGTCCTTCATGAGTATGTAAATGCTG
CTGGGATTACAGGTGGCTCTGGAAGTTCAGGTGGAGGCT
CGGGTGGCGGCAGTTCGAGAGATCATATGGTTCTCCACG
AATACGTTAACGCCGCAGGCATCACTGGCAGTGGTGGAT
CTGGCAGCGGGAGCGGCTCTGGAGGTAGCAGTCGCGAC
CATATGGTACTACATGAATATGTCAATGCAGCCGGAATAA
CCGGATCCGGAAGTGGCTCAAGCGGAGGAGGAAGTAGTG
GAAGTTCTCGGGATCACATGGTGCTGCATGAGTATGTGAA
CGCGGCGGGTATAACTGGTTCGGGAGGCTCAGGTAGCGG
CAGTTCAGGAGGAAGCGGGTCCCGAGACCATATGGTGCT
TCACGAATACGTAAACGCAGCTGGCATTACTGGGTCAGGA
GGTTCAGGAGGGTCTGGTTCTGGATCAGGAGGTAGCAGG
GATCACATGGTACTCCATGAGTACGTGAACGCTGCTGGAA
TCACAGGCGGTAGCAGTGGTGGAAGTAGCGGCAGCGGC
GGCAGTAGCTCACGGGACCATATGGTCCTGCACGAATAT
GTCAATGCTGCCGGTATCACCGGGAGTGGTGGGTCCGGC
GGGAAATTCATG 
Pex26-ALDP 
 
TCCTCCCTGCACTTCCTCTACAAGCTGGCCCAGCTCTTCC
GCTGGATCCGGAAGGCTGCATTTTCTCGCCTCTACCAGCT
CCGCATCCGTGACGGATTCCTGTGCCGGGAGACGGGGCT
GCTGGCCCTGCACTCGGCCGCCTTGGTGAGCCGCACCTT
CCTGTCGGTGTATGTGGCCCGCCTGGACGGAAGGCTGGC
CCGCTGCATCGTCCGCAAGGACCCGCGGGCTTTTGGCTG
GCAGCTGCTGCAGTGGCTCCTCATCGCCCTCCCTGCTAC
CTTCGTCAACAGTGCCATCCGTTACCTGGAGGGCCAACTG
GCCCTGTCGTTCCGCAGCTGA 
ACBD5 TMD-T  TCTCCTGGTGTGCTAACGTTTGCCATCATATGGCCTTTTAT
TGCACAGTGGTTGGTGTATTTATACTATCAAAGAAGGAGA
AGAAAAAGAAACTGA 
VAPB TMD-T CTTAGCACCCGGCTCTTGGCTCTGGTGGTTTTGTTCTTTAT
CGTTGGTGTAATTATTGGGAAGATTGCC 
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4.3 Results: 
4.3.1. Split superfolder green fluorescent protein (spGFP) technology can 
be used to assess contacts between peroxisomes and the ER: 
In order to create a fluorescence-based sensor of organelle proximity, the split 
superfolder variant of GFP (spGFP) was used. The GFP1-10 fragment 
(spGFP1-10-Pex26-ALDP) was targeted to the peroxisomal membrane and the 
GFP11 fragment (spGFP11x7) was targeted to the ER membrane. The specific 
details on the design and cloning of these constructs are outlined in Sections 
4.1 and 4.2. 
The constructs were first tested for their correct localisation. For this, two 
untargeted fragments of spGFP were used; Untargeted GFP1-10 and Kate-β11. 
Individually both fragments produce no green fluorescent signal, however, Kate-
β11 is fused to RFP so is visible at 594 nm. Both fragments also have a 
cytosolic localisation individually, however, when bound to a targeted 
complementary spGFP fragment, they should localise at the targeted organelle 
(Cieri et al., 2018).  
In order to confirm that these constructs were completely untargeted and only 
localised to the cytosol, both untargeted-GFP1-10 and Kate-β11 were co-
transfected in COS-7 cells. This produced a green fluorescent signal that could 
be observed in the cytosol (Fig. 4.7). 
To confirm that the spGFP1-10-Pex26-ALDP construct localised to 
peroxisomes, the construct was co-transfected in COS-7 cells with Kate-β11. 
This produced small, evenly distributed punctate structures identical to those 
seen with traditional peroxisomal staining, suggesting that this construct 
successfully targets to peroxisomes. The spGFP11x7 construct was co-
transfected in COS-7 cells with the untargeted GFP1-10 construct. This showed 
a clear staining of the ER network surrounding the nucleus of the cell (Fig. 4.7). 
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Fig. 4.7. Untargeted spGFP constructs show correct targeting of spGFP1-
10-Pex26-ALDP and spGFP11x7. COS-7 cells were transfected with (A) 
untargeted GFP1-10 and Kate-β11 showing clear cytosolic localisation of the 
recombined spGFP fragments; (B) spGFP11x7 and untargeted GFP1-10 
showing clear staining of the ER network, and (C) spGFP1-10-Pex26-ALDP and 
Kate-β11 showing clear peroxisomal staining. Scale bars: 20µm. 
To confirm whether the recombined spGFP1-10-Pex26-ALDP and spGFP11x7 
constructs would label peroxisome-ER contact sites, both constructs were 
transfected into COS-7 cells. In most cells, this resulted in the formation of 
many green fluorescent signals. The transfected cells were also immuno-
stained with the peroxisomal membrane maker PEX14 to label peroxisomes. 
This was to provide an indication of whether the fluorescent signals observed 
recognised areas of peroxisome-ER juxtaposition. The green fluorescent 
signals appeared to colocalise with peroxisomes. COS-7 cells were also 
transfected with each spGFP construct individually to confirm that, when 
expressed alone, the constructs did not produce any fluorescence. In both 
cases, no fluorescence was seen, only autofluorescence of the cells could be 
observed (data not shown). 
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Fig. 4.8. spGFP1-10-Pex26-ALDP and spGFP11x7 can label peroxisome-ER 
contact sites. (A) COS-7 cells expressing both spGFP1-10-Pex26-ALDP and 
spGFP11x7. Clear green fluorescent punctate structures can be seen, 
indicating contacts between peroxisomes and the ER (B) Peroxisomes labelled 
with PEX14. (C) Overlay of green fluorescent signals from the recombined 
spGFP fragments with labelled peroxisomes. (D) Zoom of (C), arrows indicate 
co-localisation of fluorescent signals with peroxisomes. Scale bars (main): 
20µm (zoom): 2µm. 
In some cells, however, a different phenotype was observed. In these cells, 
there appeared to be a reduction in the number of peroxisomes and the 
recombined spGFP constructs appeared to localise to other cellular structures 
(Fig. 4.9). This change in phenotype was also observed in control cells where 
the spGFP1-10-Pex26-ALDP construct was expressed alone but this was not 
observed when the spGFP11x7 construct was expressed alone (data not 
shown), suggesting that the change in phenotype was caused by expression of 
the spGFP1-10-Pex26-ALDP construct and not caused by recombination of the 
spGFP constructs. In addition, the same phenotype was also observed when 
the spGFP1-10-Pex26-ALDP construct was expressed with untargeted Kate-
β11 (Fig. 4.9). 
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Fig. 4.9. Expression of spGFP1-10-Pex26-ALDP leads to mistargeting and 
a reduction in peroxisome number in some cells. (A) COS-7 cells 
expressing both spGFP1-10-Pex26-ALDP and spGFP11x7. Some green 
fluorescent punctate structures can be seen, as well as other structures (B) 
Peroxisomes labelled with PEX14. Peroxisomes appear clustered and their 
number is reduced (C) Overlay of green fluorescent signals from the 
recombined spGFP fragments with labelled peroxisomes. (D) Zoom of (C), 
arrows indicate co-localisation of fluorescent signals with peroxisomes. (E) 
spGFP1-10-Pex26-ALDP expressed with Kate-β11 showing mistargeting of 
green fluorescent signals to other cellular structures. Scale bars (main): 20µm 
(zoom): 2µm. 
The structures to which the spGFP1-10-Pex26-ALDP construct and the 
recombined spGFP constructs colocalised appeared to be mitochondria. To 
confirm this, COS-7 cells expressing both spGFP constructs were immuno-
stained with the mitochondrial marker ATPB. In some cells, the recombined 
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spGFP constructs co-localised with the labelled mitochondria, however, in most 
cells, this co-localisation was not seen (Fig. 4.10). 
 
Fig. 4.10. Staining with mitochondrial marker ATPB reveals that spGFP1-
10-Pex26-ALDP can mistarget to mitochondria. (A) COS-7 cells expressing 
both spGFP1-10-Pex26-ALDP and spGFP11x7 where mistargeting is apparent. 
(B) Mitochondria are labelled with ATPB (C) Overlay of green fluorescent 
signals from the recombined spGFP fragments with labelled mitochondria. Co-
localisation with mitochondria can be seen (D) Zoom of (C), to show co-
localisation of green fluorescent staining with mitochondria. (E) COS-7 cells 
expressing both spGFP1-10-Pex26-ALDP and spGFP11x7 where no 
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mistargeting appears. (F) Mitochondria are labelled with ATPB (G) Overlay of 
green fluorescent signals from the recombined spGFP fragments with labelled 
mitochondria. No co-localisation with mitochondria can be seen (H) Zoom of 
(G), to show a lack of co-localisation of the green fluorescent signals with 
mitochondria. Scale bars (main): 20µm (zoom): 2µm. 
The number of green fluorescent signals and the number of peroxisomes per 
cell (nucleus) were also quantified. For this, a total of 30 cells were chosen from 
each of 3 experimental repeats. In this case, only cells with a normal phenotype 
and no mistargeting of the constructs were chosen for quantification. An 
average of 96.87 ± 13.19 fluorescent signals were produced per cell (nucleus) 
and there was an average of 204.7 ± 39.24 peroxisomes per cell (nucleus). The 
average percentage of peroxisomes in contact with the ER is therefore 58.46 ± 
4.21% (Fig. 4.11). 
 
 
Fig. 4.11. (A) Quantitative analysis of the number of fluorescent signals per cell 
(nucleus) formed when spGFP1-10-Pex26-ALDP and spGFP11x7 are 
expressed individually and together in COS-7 cells and the mean number of 
peroxisomes labelled with PEX14. (B) The representative percentage of 
peroxisomes in contact with the ER as shown by the co-expression of spGFP1-
10-Pex26-ALDP and spGFP11x7. Data are presented as mean ± SEM. Data 
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were analysed with a two-tailed, unpaired t test (*, P < 0.05). n = 30 cells. Data 
shown are the result of three independent experiments. 
4.3.2. A spGFP1-10 construct targeted to peroxisomes via the ACBD5 
TMD-T region shows improved targeting: 
Although the spGFP1-10-Pex26-ALDP construct produced desirable results in 
most cells, obvious mistargeting to mitochondria occurred in other cells. 
Therefore, it was decided to try a new peroxisome-targeted GFP1-10 construct 
with a different targeting sequence to allow for more uniform results following 
transfection into cells. This construct was targeted to peroxisomes via the 
transmembrane domain and tail (TMD-T) region of peroxisome contact site 
protein ACBD5. 
This construct was first tested for its correct localisation in cells. COS-7 cells 
were transfected with the spGFP1-10 construct and the untargeted Kate-β11 
construct. The resulting recombined spGFP targeted to structures resembling 
peroxisomes, confirming that the construct is correctly targeted (Fig. 4.12). 
 
Fig. 4.12. spGFP1-10 correctly targets to peroxisomes. COS-7 cells were 
transfected with spGFP1-10 and Kate-β11. The resulting green fluorescent 
punctate structures resemble peroxisomes. Scale bar: 20µm 
COS-7 cells were then transfected with spGFP1-10 and spGFP11x7. This 
resulted in the formation of many green fluorescent signals (Fig. 4.13). Cells 
were again immuno-stained with peroxisome membrane marker PEX14 which 
showed clear co-localisation of the green fluorescent signals with peroxisomes 
(Fig. 4.13). This indicates that the recombined constructs also recognise 
peroxisome-ER juxtapositions. The problem of overexpression leading to 
mistargeting of the constructs was not observed with this version of the 
spGFP1-10 construct, suggesting that this is a more robust peroxisome-
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targeted construct. As a control, the spGFP1-10 construct was also transfected 
into COS-7 cells alone to confirm that the construct does not produce 
fluorescence individually. No fluorescence was observed, only natural 
autofluorescence of the cells was seen (data not shown). 
Fig. 4.13. spGFP1-10 and spGFP11x7 can label peroxisome-ER contact 
sites. (A) COS-7 cells expressing both spGFP1-10 and spGFP11x7. Clear 
green fluorescent punctate structures can be seen, indicating contacts between 
peroxisomes and the ER (B) Peroxisomes labelled with PEX14. (C) Overlay of 
green fluorescent signals from the recombined spGFP fragments with labelled 
peroxisomes. (D) Zoom of (C), arrows indicate co-localisation of fluorescent 
signals with peroxisomes. Scale bars (main): 20µm (zoom): 2µm. 
The number of green fluorescent dots and the number of peroxisomes was also 
quantified in 30 cells from each of 3 experimental repeats. In this case, an 
average of 64.98 ± 4.45 green fluorescent signals were formed per cell 
(nucleus) and there was an average of 94.12 ± 6.79 peroxisomes per cell 
(nucleus). This shows that an average of 78.83 ± 3.67% of peroxisomes are in 
contact with the ER (Fig. 4.14).  
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Fig. 4.14. (A) Quantitative analysis of the number of fluorescent signals per cell 
(nucleus) formed when spGFP1-10 and spGFP11x7 are expressed individually 
and together in COS-7 cells and the mean number of peroxisomes labelled with 
PEX14 (B) The representative percentage of peroxisomes in contact with the 
ER as shown by the co-expression of spGFP1-10 and spGFP11x7. Data are 
presented as mean ± SEM. Data were analysed with a two-tailed, unpaired t 
test (***, P < 0.001). n = 30 cells. Data shown are the result of three 
independent experiments. 
4.3.3. Expression of split superfolder GFP appears to increase contacts 
between peroxisomes and the ER: 
Since the introduction of split superfolder GFP technology and its use in 
analysing contacts between organelles, literature in the field has been conflicted 
regarding whether the binding of the GFP1-10 and 11 fragments is reversible. 
The concern lies within the idea that if the binding between the two fragments is 
irreversible, this would lead to artificial tethering between the two organelles to 
which the fragments are targeted, subsequently altering the results observed.  
It was considered that artificial tethering of organelles could be a possibility in 
this peroxisome-ER-targeted spGFP system. In order to assess whether this 
was taking place when co-expressing the peroxisome and ER-targeted 
spGFP1-10 and 11 fragments, the Duolink® assay was performed on cells 
expressing targeted spGFP constructs. It was established from previous 
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experiments in this study that overexpressing proteins which are known to 
increase peroxisome-ER contact sites leads to a significant increase in the 
number of fluorescent dots produced from the Duolink® assay. Therefore, the 
hypothesis was made that if the expression of targeted spGFP constructs 
increased peroxisome-ER contact sites, then a significant increase in the 
number of fluorescent dots produced from the Duolink® assay would be 
observed.  
COS-7 cells were grown on glass-bottom dishes prior to transfection with both 
spGFP1-10 and spGFP11x7 as in previous experiments. As a control, cells 
were only transfected with GFP-SKL to label peroxisomes. 24 hours post-
transfection, the Duolink® assay was performed. Peroxisomal protein ACBD5 
and ER protein VAPB were labelled with rabbit anti-ACBD5 and mouse anti-
VAPB primary antibodies respectively, and the Duolink® assay was performed 
(Fig. 4.15). Before carrying out this experiment, it was confirmed that these 
antibodies will not bind to the ACBD5 or VAPB targeting sequences on the 
spGFP fragments through comparing the immunogen sequence of these 
antibodies to the targeting sequences used. This ensures that the Duolink® 
assay will only label endogenous ACBD5 and VAPB proteins. The resulting 
slides were analysed and the number of red fluorescent dots produced from 30 
cells transfected with spGFP1-10 and spGFP11x7 constructs was quantified. 
An average of 15.12 ± 1.23 red fluorescent signals were formed per cell 
(nucleus). In control cells, an average of 7.68 ± 0.57 red fluorescent signals 
were formed per cell (nucleus). The number of red fluorescent signals produced 
from cells expressing spGFP constructs was significantly higher than the control 
cells (P≤0.001). This suggests that expression of peroxisome/ER-targeted 
spGFP constructs may increase contact between the organelles (Fig 4.15). 
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Fig. 4.15. Expression of spGFP1-10 and spGFP11x7 increases the number 
of fluorescent signals formed by the Duolink® assay. (A) COS-7 cells 
transfected with spGFP1-10 and spGFP11x7. The Duolink® assay was 
performed using ACBD5 and VAPB as target proteins. Proximity between 
peroxisomes and the ER is depicted as red fluorescent signals. (B) Green 
fluorescent signals produced from recombination of the spGFP fragments (C) 
Overlay of red fluorescent signals from the Duolink® assay with recombined 
spGFP signals (D) Zoom of (C), arrow indicates close proximity of red 
fluorescent Duolink® signals with recombined spGFP signals. (E) COS-7 cells 
transfected with GFP-SKL. The Duolink® assay was performed using ACBD5 
and VAPB as target proteins. Proximity between peroxisomes and the ER is 
depicted as red fluorescent signals. (F) Peroxisomes labelled with GFP-SKL. 
(G) Overlay of red fluorescent signals from the Duolink® assay with labelled 
peroxisomes. (H) Zoom of (G), arrows indicate close proximity of fluorescent 
signals with peroxisomes. Scale bars (main): 20µm (zoom): 2µm. (I) 
Quantitative analysis of the number of red fluorescent signals produced per cell 
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(nucleus) following the use of the Duolink® assay to assess the change in the 
number of peroxisome-ER contact sites following expression of spGFP1-10 and 
spGFP11x7. Data are presented as mean ± SEM. Data were analysed with a 
two-tailed, unpaired t test (***, P < 0.001). n = 30 cells. Data shown are the 
result of three independent experiments. 
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4.4 Discussion: 
Another tool optimised in this study was the split superfolder (spGFP) system. 
This represents an additional robust method to investigate intracellular protein 
and organelle interactions. In this study, the spGFP system has been shown to 
be a powerful tool to study peroxisome-ER contact sites, allowing them to be 
effectively visualised and quantified. To date, the present study is the first 
application of a split GFP system to study peroxisome-ER interactions in 
mammalian cells.  
The spGFP system has many advantages as a tool to monitor protein and 
organelle interactions. Most importantly, the spGFP system is conceptually 
simple and due to its high modularity and flexibility it can be used to visualise 
complexes formed between virtually any combination of proteins in a wide 
variety of cell types and organisms (Kerppola, 2006). For this reason, it has 
been successfully employed in a recent study to investigate contact sites 
between multiple organelle pairs in both yeast and mammalian cells (Kakimoto 
et al., 2018). It has also been shown to be capable of monitoring organelle 
interactions over a range of distances through varying the length of the spacer 
between the GFP11 fragment and its targeting sequence (Cieri et al., 2018), 
permitting its application in a range of biological systems. Moreover, this system 
is praised for its intrinsic brightness and stability (Cieri et al., 2018), traits that 
are not often seen with the use of other split fluorescent proteins, such as 
ddGFP (Alford et al., 2012a).  
Another advantage of this system, and other BiFC methods, over standard 
biochemical methods to study protein interactions, such as coIP, is that the 
interactions can be visualised within their native cellular environment, reducing 
the potential for disruption of endogenous interactions (Kerppola, 2006). 
Although in this study, the spGFP system was only employed in fixed cells, the 
system can also easily be used in live cells and visualised with live cell imaging. 
This not only allows for dynamic, or even transient, interactions to be visualised, 
but it also eliminates potential artifacts that can be caused by fixation of cells 
(Kerppola, 2006). Furthermore, the spGFP system is a relatively inexpensive 
method for the study of organelle contact sites, particularly when compared to 
other methods commonly used for this purpose, such as EM. It also does not 
require any specialist equipment. Moreover, this system is technically 
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straightforward in its application. The design of the spGFP fragments is the 
most challenging step as this requires knowledge of the sequence of an 
abundant organelle membrane protein or contact site protein that will be 
sufficient to target the fragments to the correct location in the cell.  
The results shown in this study demonstrate that spGFP is an effective system 
to visualise peroxisome-ER contact sites. The peroxisome-targeted spGFP1-10 
construct and the ER-targeted spGFP11x7 construct were shown to target 
specifically to peroxisomes and the ER, respectively (Fig. 4.7, Fig. 4.12). When 
co-transfected, the resulting fluorescence was also shown to co-localise with 
peroxisomes, indicating that this system specifically labels peroxisome-ER 
contact sites (Fig. 4.13). The punctate fluorescent structures produced from the 
recombination of these spGFP fragments are consistent with those seen using 
this system to assess mitochondria-ER contact sites in mammalian cells (Cieri 
et al., 2018; Kakimoto et al., 2018; Yang et al., 2018). Using the spGFP1-10 
construct, the percentage of peroxisomes in contact with the ER was 80% (Fig. 
4.14). This is only slightly higher than published EM data which shows that at a 
given moment around 65-70% of peroxisomes are in contact with the ER in 
COS-7 cells (Costello et al., 2017a), suggesting that this system is a reliable 
method to study peroxisome-ER interactions. Moreover, when each construct 
was tested individually in cells, no fluorescent signal could be observed 
whatsoever (data not shown), indicating that the signals produced from co-
expressing the constructs is indicative of genuine recombination of the 
fluorescent fragments. 
In contrast, the first construct created for this study, spGFP1-10-Pex26-ALDP, 
was not as effective. It appeared to localise incorrectly in some cells when 
expressed both with the untargeted Kate-β11 construct and with the ER-
targeted spGFP11x7 (Fig. 4.9). Immunostaining with the mitochondrial marker 
ATPB confirmed that the construct mistargeted to mitochondria (Fig. 4.10). This 
mistargeting was not expected as the PEX26-ALDP sequence has previously 
been reported to target specifically to peroxisomes (Halbach et al., 2006; Castro 
et al., 2018a). 
Despite the many benefits of using the spGFP system to study organelle 
contact sites, it does harbour some limitations to its applicability which should 
be taken into consideration when interpreting results. The main question 
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surrounding the use of all BiFC methods, including spGFP is whether the 
formation of the reconstituted fluorescent complex is reversible. Ideally, this 
system should be reversible in order to minimise disruption of the biological 
system, especially as we now understand that interactions between organelles 
can often be dynamic and transient (Eisenberg-Bord et al., 2016). Therefore, an 
irreversible reaction between the spGFP fragments could have the potential to 
artificially tether the organelles, creating new contacts and altering interpretation 
of the results. In vitro studies utilising split GFP systems have shown that this 
reaction is often irreversible (Cabantous et al., 2005; Magliery et al., 2005; 
Pédelacq et al., 2006), however, it had never been tested whether this reaction 
would be reversible if there were forces to pull the two fragments apart, which 
may occur if they were tethered to opposing organelle membranes in vivo. 
Several studies that have recently employed spGFP to study mitochondria-ER 
interactions have investigated this possibility. One such study took the approach 
of comparing the number of mitochondria-ER interactions using EM in a cell line 
where the spGFP fragments were not expressed and in a cell line stably 
transfected with mitochondria and ER-targeted spGFP fragments. In this case, it 
was found that expression of the spGFP fragments did not change the number 
or size of mitochondria-ER contacts, suggesting that the association of the 
spGFP fragments is reversible in these settings (Yang et al., 2018). In contrast, 
another publication assessing mitochondria-ER contact sites using the spGFP 
system had conflicting results regarding the reversibility of the system. In this 
study, expression of the spGFP probes on the mitochondria and the ER was 
shown to rescue the growth defects of cells which are unable to form 
mitochondria-ER contacts, analogous to the effect of expressing a genuine 
artificial tethering protein (Kakimoto et al., 2018). This suggests that expression 
of the spGFP fragments can form new, irreversible contacts between 
organelles. The primary difference between these two studies is that the first 
used a cell line which stably expresses the spGFP fragments, whereas the 
second did not. It could be possible that stable expression of the constructs 
enables an optimal expression level at which irreversible binding of the 
fragments does not occur.  
It was not known whether complementation of the spGFP fragments was 
reversible in the present study. In order to test this, the Duolink® assay was 
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performed on cells expressing spGFP fragments targeted to peroxisomes and 
the ER. Cells expressing the spGFP fragments produced a significantly higher 
number of fluorescent signals in the Duolink® assay than cells not expressing 
the system (Fig. 4.15). As Duolink® shows an increase in proximity between 
organelles, this suggests that expression of the spGFP fragments increases the 
frequency of contacts between peroxisomes and the ER. The ideal control for 
this experiment would have been to express a genuine peroxisome-ER artificial 
tethering protein and compare these results to cells expressing the spGFP 
fragments, however, due to time constraints, this was not possible in this study. 
It would also be interesting to express the spGFP fragments in a cell line where 
the ACBD5 protein is either silenced or knocked-out as it is known that silencing 
ACBD5 significantly reduces peroxisome-ER contacts (Costello et al., 2017a). 
Thus, if expressing the spGFP fragments significantly increases the number of 
peroxisome-ER contacts in this context to the wild-type level, it could be 
concluded that the reconstitution of these fragments is irreversible and leads to 
artificial tethering of the organelles. 
Another issue with the use of spGFP which has been noted in several studies is 
that high expression levels of both fragments can lead to alteration of the 
morphology of one of the targeted organelles. Both of the aforementioned 
studies reported changes in mitochondrial morphology when the spGFP 
fragments were expressed at high levels in both yeast and mammalian cells 
(Kakimoto et al., 2018; Yang et al., 2018). In the present study, it was noted that 
in cells with high expression levels of the spGFP constructs, that “clustering” of 
peroxisomes seemed to occur. This was the case with both the spGFP1-10-
Pex26-ALDP and spGFP1-10 constructs (Fig. 4.16). It is not known specifically 
why this phenotype occurs, however, as the ER is known to wrap around 
peroxisomes (Novikoff and Novikoff, 1972; Zaar et al., 1987; Grabenbauer et 
al., 2000), it is possible that artificial tethering of the two organelles, potentially 
caused by expression of the spGFP fragments could lead to peroxisomes 
clustering in areas where they are bound by the ER. Moreover, peroxisomal 
clustering is also known to occur prior to pexophagy (Yamashita et al., 2014), 
suggesting that high expression levels of the spGFP fragments may be toxic to 
the peroxisomes, leading to the onset of pexophagy. This phenotype could be 
avoided with the creation of a cell line which stably expresses the spGFP 
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fragments to ensure that the expression level of the fragments is at an optimal 
level. 
 
Fig. 4.16. Clustering of peroxisomes seems to occur with high expression 
levels of the spGFP constructs. (A) spGFP1-10 or (E) spGFP1-10-Pex26-
ALDP and spGFP11x7 expressed in COS-7 cells. Clustering of the green 
fluorescent signal can be observed. (B, F) Peroxisomes labelled with PEX14. 
Peroxisome number appears reduced and clustering is visible. (C, G) Overlay of 
green fluorescent signals with labelled peroxisomes. (D, H) Zoom of (C, G). 
Clusters of the recombined spGFP fragments co-localise with clustered 
peroxisomes. Arrows indicate co-localisation. Scale bars (main): 20µm (zoom): 
2µm. 
Considering both the advantages and the disadvantages of the spGFP system, 
it can be concluded that it is an effective system to study peroxisome-ER 
interactions, however, the results should be analysed with caution. The potential 
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of spGFP to perturb the natural biological system, by inducing organelle 
interactions or by altering organelle morphology, cannot completely be ruled out 
by this study or by others. The creation of a stably expressing cell line in the 
future could help to minimise these effects by ensuring an optimal expression 
level. Until then, this system can be used to detect and analyse peroxisome-ER 
contact sites and help to uncover the physiological roles of these sites. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98 
 
Chapter 5:  
Using Duolink® and split superfolder GFP systems to 
assess changes in peroxisome-endoplasmic reticulum 
contact sites following changes in physiological cellular 
conditions. 
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5.1. Introduction: 
Following optimisation of both Duolink® and the spGFP fluorescent reporter 
system to visualise and quantify peroxisome-ER interactions, these systems 
were used to assess the effect of altering the physiological cellular conditions 
on the integrity and number of peroxisome-ER contact sites formed.  
It is known that peroxisome-ER associations are required for several essential 
peroxisomal metabolic processes including the production of polyunsaturated 
fatty acids (Sprecher and Chen, 1999), bile acid synthesis (Mihalik et al., 2002) 
and the biosynthesis of plasmalogens (Braverman and Moser, 2012), which has 
been shown to be impacted when peroxisome-ER associations are disrupted 
(Hua et al., 2017; Herzog et al., 2018). Additionally, cooperation between these 
organelles has been implicated in de novo peroxisome biogenesis and also 
peroxisomal growth and division (Raychaudhuri and Prinz, 2008; Hettema et al., 
2014) likely through the transfer of membrane lipids. This is corroborated by the 
finding that an absence of contact between peroxisomes and the ER leads to a 
reduction in peroxisomal membrane expansion (Costello et al., 2017a). Specific 
details of these processes and interplay between peroxisomes and the ER can 
be found in Section 1.4.6.  
Despite our growing understanding of the importance of cooperation between 
these organelles, the specific role of peroxisome-ER contact sites in these 
processes is still not fully understood. At present, it cannot be ascertained 
whether contact sites play a direct role in these processes, for example, through 
enabling transfer of the substrates or end products of peroxisome metabolism 
between the organelles (Wanders et al., 2016), or an indirect role through 
simply providing proximity between the organelles to enable vesicular transfer 
of products. Currently, the only evidence for the involvement of peroxisome-ER 
tethering in a physiological role is the finding that plasmalogen production is 
reduced when contact site formation is disrupted (Hua et al., 2017; Herzog et 
al., 2018). However, some hypotheses have been made for the cooperation of 
these organelles. One such hypothesis is that contact between these organelles 
may play a direct or indirect role in peroxisomal β-oxidation (Castro et al., 
2018b). Interestingly, all patients with defects in the peroxisomal contact site 
protein, ACBD5, have elevated levels of VLCFAs, which are exclusive 
substrates of peroxisomal β-oxidation (Ferdinandusse et al., 2017; Yagita et al., 
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2017a). It is possible that this functional defect could be caused as ACBD5 has 
been hypothesised to bind directly to ER-derived and cytosolic VLCFAs and 
recruit them to peroxisomes where β-oxidation can take place (Ferdinandusse 
et al., 2017). 
Previous studies have successfully used both Duolink® and split fluorescent 
reporter systems to detect changes in the number of mitochondria-ER contact 
sites formed following induction of stress conditions, changes in organelle 
morphology and the addition of stimuli (Stoica et al., 2016; Cieri et al., 2018; 
Yang et al., 2018). Therefore, it was hypothesised that these systems could be 
used to assess changes in the number of peroxisome-ER contacts sites in 
response to altered physiological conditions. Following initial observations, it 
was decided that the Duolink® system may be better suited to assess an 
increase in the number of contact sites formed, rather than showing a decrease. 
This is because it was found that the number of fluorescent signals formed 
using this system is much lower than the estimated number of endogenous 
contact sites which has been calculated through the use of EM (Costello, et al., 
2017a). However, the number of fluorescent signals formed seems to increase 
significantly following an induction in contact site formation, for example through 
the overexpression of contact site proteins.  
Following from the hypothesis that peroxisome-ER contact may be implicated in 
peroxisomal fatty acid β-oxidation, it was decided to test whether the addition of 
excess oleic acid would increase contacts between peroxisomes and the ER in 
response to increased β-oxidation. Oleic acid (18:1) is a long chain 
monounsaturated fatty acid and is known to be broken down by fatty acid β-
oxidation (Ren and Schulz, 2003). It was hypothesised that an excess of this 
fatty acid would induce fatty acid β-oxidation in the cell, thereby increasing the 
number of peroxisome-ER contacts if, indeed, these play a role in the process. 
Moreover, addition of excess oleic acid has been shown to affect the number of  
contacts between peroxisomes and other organelles in a previous study (Valm 
et al., 2017). 
In addition, it was decided to test the effect of adding excess arachidonic acid, a 
polyunsaturated fatty acid, on the number of peroxisome-ER contact sites 
formed. Arachidonic acid is a very long chain polyunsaturated fatty acid (C20:4) 
which can be broken down by β-oxidation (Gordon et al., 1994). It is known to 
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induce the formation of tubular peroxisomes (Schrader et al., 1998) as well as 
stimulating peroxisome proliferation (Reddy and Mannaerts, 1994). It has been 
reported that the ER transfers membrane lipids to peroxisomes, mainly for 
peroxisome biogenesis (Raychaudhuri and Prinz, 2008) and that organelle 
tethering can facilitate this transfer (Prinz, 2010). Therefore, it was thought that 
a stimulation of peroxisome proliferation through the addition of excess 
arachidonic acid may increase contacts between peroxisomes and the ER to 
facilitate lipid transfer for peroxisome biogenesis. For the addition of both oleic 
and arachidonic acid, cells were treated with an appropriate concentration of the 
respective fatty acid and the Duolink® assay was carried out in order to assess 
whether a change in peroxisome-ER contact sites could be reflected by a 
change in the number of fluorescent signals produced. 
The effect of cellular stresses on the formation of peroxisome-ER contact sites 
is also not well understood. It is known that conditions, such as nutrient-
starvation, lead to autophagic degradation of peroxisomes (Hara-Kuge and 
Fujiki, 2008), which could potentially reduce the number of peroxisome-ER 
contact sites present in a cell. However, it has also been identified, using a split 
fluorescent reporter system, that the number of mitochondria-ER contact sites 
increases following nutrient-starvation (Yang et al., 2018). Due to the similarity 
and frequent cross-over between peroxisomal and mitochondrial phenotypes 
(Schrader and Yoon, 2007), it was thought that this effect may also be present 
in peroxisome-ER contacts following the same conditions. In order to 
investigate this, the spGFP system was used and the number of fluorescent 
signals were quantified in both starved and un-starved cells to reflect changes 
in the number of peroxisome-ER contact sites formed.  
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5.2. Materials and methods: 
5.2.1. Oleic acid and arachidonic acid treatment: 
COS-7-GFP-SKL cells were grown on 19 mm glass coverslips at 37°C with 5% 
CO2 and 95% humidity for 8 hours. After this time, oleic acid was added to cells 
at three different concentrations: 25, 50 and 100 µM or arachidonic acid was 
added to cells at two different concentrations: 25 and 50 µM. Ethanol was 
added as a control. In the case of oleic acid treatment, BODIPY 558/568 C12 
was added to cells to stain lipid droplets. Cells were then incubated at 37°C with 
5% CO2 and 95% humidity overnight. After this time, the cells were washed with 
1x PBS and fixed in 4% paraformaldehyde in PBS (pH 7.4) for 20 minutes at 
room temperature. Cells were then washed three times for 5 minutes with PBS. 
To prepare the slides, coverslips were washed once in Milli-Q water and 
mounted in Mowiol 4-88 containing n-propyl gallate as an anti-fading reagent 
(3:1 mowiol with n-propyl gallate). The cells were then imaged using 
fluorescence microscopy as described in Section 2.5. 
5.2.2. Duolink® assay with fatty acid treatment: 
COS-7-GFP-SKL cells were grown 3.5-cm-diameter glass bottom dishes 
(Cellview; Greiner BioOne) and incubated for 8 hours at 37°C with 5% CO2 and 
95% humidity. After this time, cells were treated with 25 µM oleic acid or 
arachidonic acid or the same quantity of ethanol as a control. Following 
overnight incubation, the Duolink® assay was performed as described in 
Section 3.2.1. Slides were then analysed with fluorescence microscopy as 
described in Section 2.5. Quantification of the fluorescent signals produced was 
performed as described in Section 2.6. 
5.2.3. spGFP assay following nutrient starvation: 
COS-7 cells were transfected using DEAE-dextran transfection with 
peroxisome-targeted spGFP1-10 and ER-targeted spGFP11x7 as described in 
Section 2.2. Following overnight incubation at 37°C with 5% CO2 and 95% 
humidity, media was changed to Hank’s Balanced Salt Solution (HBSS), a 
medium which lacks amino acids but contains sufficient glucose to ensure cell 
survival over a 24-hour period (Sargent et al., 2016). Cells were nutrient starved 
for 24 hours. As a control, media was replaced with complete media (DMEM 
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+/+) at this time point. Following this 24-hour incubation, cells were fixed and 
immuno-stained with anti-PEX14 antibody to label peroxisomes as described in 
Section 2.4. Slides were then analysed with fluorescence microscopy as 
described in Section 2.5. Quantification of the fluorescent signals produced was 
performed as described in Section 2.6. 
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5.3. Results: 
5.3.1. Addition of excess oleic acid increases the size of lipid droplets: 
In order to first determine the appropriate concentration of oleic acid to use in 
this experiment, increasing concentrations of oleic acid were individually added 
to COS-7-GFP-SKL cells. The concentrations used were 0, 25, 50 and 100 µM. 
The cells were also stained with BODIPY 558/568 C12 to label lipid droplets. 
Cells were fixed and analysed by fluorescence microscopy to assess the overall 
appearance of the cells, including the number and distribution of peroxisomes 
and the formation of lipid droplets. The size of lipid droplets increased as the 
concentration of oleic acid increased. With all concentrations, peroxisome 
number and distribution were uniform (Fig. 5.1). It was decided to use a 
concentration of 25 µM oleic acid for subsequent experiments as this appeared 
to be sufficient to induce an effect within the cells, as seen by a clear increase 
in the size of lipid droplets but was still a low concentration to reduce the 
potential of causing toxicity within the cell.  
 
Fig. 5.1. COS-7-GFP-SKL cells were treated with increasing concentrations 
of oleic acid. Lipid droplets were stained with BODIPY and appear to increase 
in size following increasing concentrations of oleic acid. The number and 
distribution of peroxisomes remains consistent. Scale bars: 20µm.  
5.3.2. Addition of excess arachidonic acid induces peroxisome tubulation: 
A similar approach was taken for determining the appropriate concentration of 
arachidonic acid. COS-7-GFP-SKL cells were treated with increasing 
concentrations of arachidonic acid (0, 25 and 50 µM). Cells were fixed and 
observed using fluorescence microscopy. In this case, it was necessary to 
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identify the minimum concentration of fatty acid that would induce peroxisomal 
tubulation without producing any toxic effects in the cell. It was decided that 25 
µM arachidonic acid was the optimum concentration to use as some tubulation 
could be observed, however, the number and distribution of peroxisomes was 
normal (Fig. 5.2). At concentrations of 50 µM, peroxisomal tubulation occurred, 
however, the number of peroxisomes appeared to be reduced and peroxisomes 
seemed to cluster around the nucleus of the cell, indicating potential toxicity to 
the cells (Fig. 5.2). 
 
Fig. 5.2. COS-7-GFP-SKL cells were treated with increasing concentrations 
of arachidonic acid. Peroxisomal tubulation is indicated by arrows at 25 and 
50 µM arachidonic acid. Scale bars: 20µm.  
5.3.3. Adding excess oleic acid to cells has no effect on the number of 
peroxisome-ER contact sites as visualised by the Duolink® system: 
After determining the optimal concentration of oleic acid to use for 
experimentation, the effect of adding an excess of this fatty acid to cells on the 
formation of peroxisome-ER contact sites was investigated. For this, the 
Duolink® system was used. COS-7-GFP-SKL cells were treated with 25 µM 
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oleic acid. The oleic acid used for this study was dissolved in ethanol, therefore, 
as a control, cells were treated with the same amount of solvent. The Duolink® 
assay was performed as described; peroxisomal protein ACBD5 and ER protein 
VAPB were labelled with rabbit anti-ACBD5 and mouse anti-VAPB primary 
antibodies, respectively. Following analysis of the slides, it was found that an 
average of 8.26 ± 0.79 fluorescent signals were formed per cell (nucleus) in 
cells treated with oleic acid compared to an average of 7.97 ± 0.66 fluorescent 
signals in control cells. The difference in the number of fluorescent signals was 
not significant, suggesting that the addition of excess oleic acid has no effect on 
the number of peroxisome-ER contact sites that can be visualised using the 
Duolink® system (Fig. 5.3). 
 
107 
 
Fig. 5.3. Addition of excess oleic acid does not change the number of 
fluorescent signals formed by the Duolink® assay. (A) Control COS-7-GFP-
SKL cells were treated with ethanol. The Duolink® assay was performed using 
ACBD5 and VAPB as target proteins. Proximity between peroxisomes and the 
ER is depicted as red fluorescent signals. (B) Peroxisomes labelled with GFP-
SKL. (C) Overlay of red fluorescent signals from the Duolink® assay with 
labelled peroxisomes (D) Zoom of (C), arrows indicate close proximity of red 
fluorescent Duolink® signals with peroxisomes (E) COS-7-GFP-SKL cells 
treated with 25 µM oleic acid. The Duolink® assay was performed using ACBD5 
and VAPB as target proteins. Proximity between peroxisomes and the ER is 
depicted as red fluorescent signals. (F) Peroxisomes labelled with GFP-SKL. 
(G) Overlay of red fluorescent signals from the Duolink® assay with labelled 
peroxisomes. (H) Zoom of (G), arrow indicates close proximity of fluorescent 
signals with peroxisomes. Scale bars (main): 20µm (zoom): 2µm. (I) 
Quantitative analysis of the number of red fluorescent signals produced per cell 
(nucleus) following the use of the Duolink® assay to assess the change in the 
number of peroxisome-ER contact sites following treatment with excess oleic 
acid. Data are presented as mean ± SEM. Data were analysed with a two-
tailed, unpaired t test (ns, not significant). n = 30 cells. Data shown are the 
result of three independent experiments. 
5.3.4. Adding excess arachidonic acid to cells has no effect on the number 
of peroxisome-ER contact sites as visualised by the Duolink® system: 
COS-7-GFP-SKL cells were treated with 25 µM arachidonic acid to assess the 
effect of the presence of an excess of this fatty acid on the formation of 
peroxisome-ER contact sites. As a control, COS-7-GFP-SKL cells were also 
treated with the same amount of ethanol, which was the diluent of the 
arachidonic acid used. The Duolink® assay was performed as described; 
peroxisomal protein ACBD5 and ER protein VAPB were labelled with rabbit 
anti-ACBD5 and mouse anti-VAPB primary antibodies, respectively. Analysis of 
the slides showed that an average of 10.23 ± 1.35 fluorescent signals were 
formed per cell (nucleus) in cells treated with arachidonic acid compared to an 
average of 12.11 ± 0.77 fluorescent signals formed in control cells. The 
difference in the number of fluorescent signals formed was not significant, 
suggesting that the addition of excess arachidonic acid has no effect on the 
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number of peroxisome-ER contact sites that can be visualised using the 
Duolink® system (Fig. 5.4). 
 
Fig. 5.4. Addition of excess arachidonic acid does not change the number 
of fluorescent signals formed by the Duolink® assay. (A) Control COS-7-
GFP-SKL cells were treated with ethanol. The Duolink® assay was performed 
using ACBD5 and VAPB as target proteins. Proximity between peroxisomes 
and the ER is depicted as red fluorescent signals. (B) Peroxisomes labelled with 
GFP-SKL. (C) Overlay of red fluorescent signals from the Duolink® assay with 
labelled peroxisomes (D) Zoom of (C), arrow indicates close proximity of red 
fluorescent Duolink® signals with peroxisomes (E) COS-7-GFP-SKL cells 
treated with 25 µM arachidonic acid. The Duolink® assay was performed using 
ACBD5 and VAPB as target proteins. Proximity between peroxisomes and the 
ER is depicted as red fluorescent signals. (F) Peroxisomes labelled with GFP-
SKL. (G) Overlay of red fluorescent signals from the Duolink® assay with 
labelled peroxisomes. (H) Zoom of (G), arrow indicates close proximity of 
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fluorescent signals with peroxisomes. Scale bars (main): 20µm (zoom): 2µm. (I) 
Quantitative analysis of the number of red fluorescent signals produced per cell 
(nucleus) following the use of the Duolink® assay to assess the change in the 
number of peroxisome-ER contact sites following treatment with excess 
arachidonic acid. Data are presented as mean ± SEM. Data were analysed with 
a two-tailed, unpaired t test (ns, not significant). n = 30 cells. Data shown are 
the result of three independent experiments. 
5.3.5. Nutrient starvation has no effect on the number of peroxisome-ER 
contact sites formed that can be visualised by split fluorescent protein 
technology: 
Following transfection with the spGFP fragments and nutrient starvation, 30 
cells were analysed from both control and starved culture conditions. The 
number of peroxisomes and the number of fluorescent signals produced from 
the recombined spGFP fragments (representing peroxisome-ER contact sites) 
were quantified. The number of peroxisomes appeared to decrease following 
starvation compared to control cells (99.56 ± 19.64 control, 65.5 ± 15.5 
starved), however, this reduction in number was not significant. The number of 
fluorescent signals per cell (nucleus) also decreased following starvation (69.69 
± 16.83 control, 40.67 ± 6.9 starved) however, this reduction was also not 
significant. The percentage of peroxisomes in contact with the ER remained 
relatively constant (73.25 ± 8.59% control, 81.04 ± 12.08% starvation - ns) (Fig. 
5.5). 
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Fig. 5.5. Nutrient starvation does not affect the number of peroxisome-ER 
contacts reported by the spGFP system. (A) Control COS-7 cells transfected 
with spGFP1-10 and spGFP11x7. (B) Peroxisomes labelled with PEX14. (C) 
Overlay of green fluorescent signals from the recombined spGFP fragments 
with labelled peroxisomes. (D) Zoom of (C), arrows indicate co-localisation of 
fluorescent signals with peroxisomes. (E) COS-7 cells starved for 24 hours 
transfected with spGFP1-10 and spGFP11x7. (F) Peroxisomes labelled with 
PEX14. (G) Overlay of green fluorescent signals from the recombined spGFP 
fragments with labelled peroxisomes. (H) Zoom of (G), arrows indicate co-
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localisation of fluorescent signals with peroxisomes. Scale bars (main): 20µm 
(zoom): 2µm. (I) Quantification of the number of peroxisomes between control 
and starved cells. (J) Quantification of the number of fluorescent signals formed 
per cell (nucleus) following recombination of the spGFP fragments between 
control and starved cells. (K) Comparison of the percentage of peroxisomes in 
contact with the ER as reported by the spGFP system between control and 
starved cells. Data are presented as mean ± SEM. Data were analysed with a 
two-tailed, unpaired t test (ns, not significant). n = 30 cells. Data shown are the 
result of one experiment. 
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5.4 Discussion: 
Although much progress has been made in understanding the structure of 
peroxisome-ER contact sites, the physiological roles of these sites have yet to 
be uncovered. Following from the success of using both the Duolink® and 
spGFP systems to study peroxisome-ER interactions, it was hypothesised that 
these systems could be used to help uncover the physiological roles of this 
inter-organelle contact.  
It was evident from results obtained earlier in this study that the Duolink® 
system is capable of reporting a significant increase in the number of 
peroxisome-ER contacts formed in a cell following protein overexpression (Fig. 
3.3, Fig.3.4). For this reason, the Duolink® system was employed to assess the 
effect of adding an excess of oleic acid to the cells on the number of 
peroxisome-ER contacts formed. It was hypothesised that this would increase 
the number of peroxisome-ER contacts due to the suggestion that cooperation 
between these organelles may be implicated in fatty acid β-oxidation. However, 
following the addition of oleic acid to cells, no significant change was observed 
in the number of fluorescent signals produced in control cells and treated cells, 
suggesting no change in the number of peroxisome-ER contact sites formed 
(Fig. 5.3). The concentration of fatty acid used was shown to have an effect on 
the cell by inducing an increase in the size of cellular lipid droplets (Fig. 5.1), 
therefore, it can be ruled out that the lack of change observed in the results is 
due to insufficient concentrations of the fatty acid. It is possible that oleic acid is 
not of a sufficient chain length that would be metabolised in peroxisomes. It is 
known that peroxisomes only break down fatty acids of a chain length of ≥C22 
(Wanders, 2004), however, the chain length of oleic acid is only C18. Thus, it is 
possible that addition of this fatty acid may impact mitochondrial fatty acid β-
oxidation, which metabolises fatty acids of this chain length (Wanders et al., 
2001a), but not that which occurs in peroxisomes. Before ruling out the 
involvement of peroxisome-ER contacts in β-oxidation, it would be interesting to 
investigate the effect of adding an excess of a fatty acid with a longer chain 
length, in particular, C26 fatty acids, as such have shown elevated levels in a 
patient with a lack of function mutation in ACBD5 (Ferdinandusse et al., 2017; 
Yagita et al., 2017a). Moreover, it has been hypothesised that C26-CoA binds 
directly to ACBD5 before being shuttled into peroxisomes for β-oxidation 
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(Ferdinandusse et al., 2017). It would also be useful to investigate the effect of 
adding C24:0-CoA as ACBD5 has also been shown to preferentially bind to this 
substrate (Yagita et al., 2017). 
The effect of adding excess arachidonic acid was subsequently investigated in 
this study. It was shown that, at concentrations of 25 µM, peroxisomal tubulation 
was induced (Fig. 5.2). This indicated that peroxisome proliferation may have 
been triggered as this morphology is induced during early stages of peroxisome 
biogenesis (Schrader et al., 2012). Therefore, this suggested that there may be 
an increase in the number of contacts formed between peroxisomes and the ER 
as cooperation between these organelles is known to be involved in peroxisome 
biogenesis (Raychaudhuri and Prinz, 2008). However, when analysed with the 
Duolink® assay, there was no significant change in the number of fluorescent 
signals produced between treated and untreated cells, suggesting no change in 
the number of peroxisome-ER contact sites formed (Fig. 5.4). It is possible that 
the ACBD5/VAPB-mediated contact sites that were investigated in this case, 
are not involved in the transfer of membrane lipids for peroxisome biogenesis, 
therefore, there was no visible increase in the number of these sites. It is also 
possible, with both arachidonic and oleic acid treatment, that the increase in the 
number of peroxisome-ER contact sites formed following stimulation was not 
sufficient to produce a significant increase in the number of fluorescent signals 
formed using the Duolink® assay. This is because it was observed earlier in this 
study that the number of fluorescent signals produced using this system is not 
identical to the actual number of peroxisome-ER contact sites in a cell. 
Therefore, it may be possible that only a small increase in contact sites may not 
be represented by an increase in fluorescent signals using this system. 
The effect of nutrient starvation on the number of peroxisome-ER contact sites 
formed was also assessed. In this case, it was decided to investigate this effect 
by using the spGFP system. It was not known whether nutrient starvation would 
have any effect on the number of peroxisome-ER contacts formed. It was found 
that the number of peroxisomes per cell (nucleus) and the number of 
fluorescent signals, indicating the number of peroxisome-ER contact sites 
formed, appear to reduce following starvation. Although the result appears to be 
approaching significance, the change was not significant (Fig. 5.5). Accordingly, 
the percentage of peroxisomes in contact with the ER did not change 
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significantly between starved and control cells (Fig. 5.5). As this experiment was 
only conducted once, it is possible that repeats could help to clarify this. It has 
been shown in previous studies that 24 hours starvation is a sufficient period of 
time to observe an effect on the number of peroxisomes in a cell (Sargent et al., 
2016), however, that study was conducted in HeLa cells, therefore, the period of 
starvation used in this study may not have been a suitable time frame to see an 
effect in COS-7 cells. Our current understanding of the function of peroxisome-
ER contact sites under conditions of cellular stress is not extensive. Therefore, 
it was hoped that the use of this system in this way may shed light on their role 
in these processes. However, from this data it can be suggested that either 
peroxisome-ER contact sites do not play a role in the response to cellular 
stresses such as nutrient starvation, or expression of the spGFP system affects 
the intrinsic biological response, potentially due to irreversible binding of the 
fragments. The latter, however, should be unlikely as changes in the number of 
contact sites following starvation and refeeding has been shown to occur using 
the spGFP system to study mitochondria-ER contact sites in the past (Yang et 
al., 2018). Nonetheless, it is still not clear from previous data in this study 
whether peroxisome-ER contact sites are subject to artificial tethering following 
expression of this system. Moreover, even if the system is reversible, the stable 
nature of the resulting refolded GFP might make subtle changes in contacts 
difficult to detect. In the future, this experiment should be repeated using the 
Duolink® assay to rule out the potential of disruption through spGFP 
expression. It would also be useful to assess the level of spGFP expression in 
both control and starved cells, using western blotting, to confirm that the level of 
expression does not change in these conditions, as this could affect the results 
observed. 
No significant changes in the number of peroxisome-ER contact sites was 
observed in these data. Unlike contact sites between organelles such as 
mitochondria and the ER, which are very well characterised, contact sites 
between peroxisomes and the ER have only recently been discovered in 
mammalian cells and little is known about their function. Therefore, it was 
difficult to know which stimuli would affect these structures. For this reason, it is 
unclear whether the lack of change seen in these data was due to limitations of 
the systems used, or perhaps the stimuli tested were not those that would affect 
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contact site formation between the organelles. In the case of Duolink®, data in 
this study has shown that an increase in the number of contact sites formed can 
easily be reported by an increase in fluorescence signals using the assay, 
however, as mentioned previously, it is not known whether small changes can 
be detected by the assay. Moreover, as the spGFP system has been 
successfully used in the past to investigate changes in contact site formation 
following changes in physiological cellular conditions, it is unlikely that the 
systems used here are to blame for the apparent lack of change observed.  
To clarify the discrepancies seen here, it would, perhaps, be better to first use 
these systems to investigate a contact site function for which we have more 
evidence. For example, it would be interesting to use these systems to 
investigate the effect of altering a biochemical pathway in which cooperation 
between peroxisomes and the ER is known to be required and observe the 
effect on the number of contact sites formed. For example, cooperation 
between peroxisomes and the ER is known to be involved in plasmalogen 
biosynthesis and disruption of ACBD5-VAPA/B mediated contacts have been 
shown to result in a reduction in plasmalogen production (Hua et al., 2017). 
Therefore, it would be interesting to employ the Duolink® system to assess cells 
from a patient suffering from RCDP as plasmalogen synthesis is impaired in this 
disease (Brites et al., 2004). 
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Chapter 6: 
Final conclusions and future directions. 
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The field of peroxisome-organelle contact sites is still very much in its beginning 
stages, and it is likely that we have only just touched the surface of 
understanding peroxisome-ER contacts. With increasing data to suggest the 
existence of physical contacts with other organelles, such as mitochondria and 
lysosomes, it has become imperative that effective and simple tools are readily 
available to study these interactions and uncover their function. The systems 
presented in this study are not only efficient and robust in their current use but 
are readily modifiable in order to easily allow visualisation of other contact sites, 
either by employing alternate target proteins in the case of Duolink®, or by 
altering the targeting sequences in the case of spGFP. It would also be possible 
to design a screening experiment to identify new proteins involved in the 
formation of contact sites, for example, by fusing the GFP1-10 fragments to 
various candidate interactors and the GFP11 fragment to an organelle of 
interest, or by conducting the Duolink® assay in a 96-well plate and using a 
variety of target proteins. This would allow simple, high-throughput screening 
which would be very difficult or even impossible before the advent of these 
systems. 
An exciting future perspective for these systems would be to employ them in 
imaging multiple interactions in one cell. For example, the GFP1-10 fragment of 
the spGFP system can easily be mutated to create either a cyan fluorescent 
protein or yellow fluorescent protein (Kamiyama et al., 2016). This could be 
targeted to mitochondria with the ER-targeted spGFP11 fragment, for instance, 
alongside the peroxisome-ER spGFP system in this study to allow simultaneous 
detection of multiple contact sites. As organelles are known to cooperate 
extensively, this could be useful in determining how changes in one contact site 
could affect another. Moreover, this could help elucidate the role of multiple 
organelle interactions in one process. For example, β-oxidation of fatty acids is 
known to require cooperation between peroxisomes and mitochondria 
(Wanders et al., 2001a) and also may require involvement from the ER 
(Ferdinandusse et al., 2017). Using this system to detect changes in contact 
site formation between the respective organelles could aid in characterising the 
role contact sites play in this essential process. It would also be possible to 
employ the Duolink® system in this way as there is a variety of fluorophore 
colours that can be used with the system.  
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Moreover, with the increasing relevance of these sites in health and disease, 
these systems would make it possible to screen patient cells in order to assess 
whether the symptoms observed are, in fact, due to a defect in contact site 
formation between peroxisomes and the ER. For this, the Duolink® system 
could be used to assess ACBD5/VAPB-mediated peroxisome-ER interactions in 
a variety of patient cell samples in a 96-well plate to enable high-throughput, 
rapid screening without the need for full genomic analysis of the patients. 
Of course, no single technique to study protein or organelle interactions is gold-
standard, as shown in this study and many others, each has their own individual 
strengths and limitations, and the optimisation of these systems is still an on-
going process. At this current time, it can be suggested that the strengths and 
limitations of these systems may render them better suited to different 
purposes. The key differences between the Duolink® and spGFP system are 
summarised in Table 6.1. 
Table 6.1. A summary of the key differences between Duolink® and spGFP 
technologies. 
 Duolink® spGFP 
Can be used in fixed cell 
studies 
✔ 
 
✔ 
 
Can be used in live cell 
studies 
X ✔ 
 
Can be used on clinical 
samples 
✔ 
 
X 
Requires transfection X ✔ 
 
Requires specific antibodies ✔ 
 
X 
Representative of the actual 
number of contact sites in a 
cell 
X ✔ 
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One general limitation of the present study is that the only imaging performed 
for the quantitative analysis of fluorescent signals in both the Duolink® and 
spGFP systems was fluorescence microscopy. This type of imaging only 
images a single plane, however, when focusing on the cells, it was evident that 
fluorescent signals could be observed in different focal planes. As quantification 
of the fluorescent signals was performed using the resulting fluorescent 
microscopy images, it is possible that fluorescent signals in other focal planes 
may not have be counted. To overcome this issue in future studies, confocal 
microscopy could be used as this would enable imaging of several focal planes, 
allowing all the fluorescent signals produced from either system to be quantified 
(Jonkman and Brown, 2015). Additionally, it may be possible to analyse the 
resulting fluorescence from the cells using flow cytometry as this would avoid 
any discrepancies in imaging or the quantification of fluorescent signals. Indeed, 
this has been carried out successfully in a study using Duolink® to study protein 
interactions (Mocanu et al., 2011). Moreover, Sigma-Aldrich now sell a 
Duolink® kit optimised for analysis in this way, called flowPLA, making this 
process incredibly simple to carry out (Duolink® PLA Technology - Protein 
Interaction | Sigma-Aldrich, 2017). In addition, flow cytometry analysis could 
also be used to assess spGFP fluorescent signals. 
Both Duolink® and the spGFP system presented in this study have been shown 
to allow effective visualisation and quantification of peroxisome-ER contact 
sites, enabling simple, rapid and, importantly, in situ visualisation of these sites 
which has never before been possible. Both systems used here are significantly 
more straightforward and affordable long-term than many other commonly used 
methods, like EM and are much easier to image with lower false-positive rates 
than systems such as FRET. Moreover, both systems are easily modifiable to 
enable the detection of other contact sites between these organelles, and 
contact sites between peroxisomes and other organelles allowing them to adapt 
to the needs of future research. Like all techniques to study organelle 
interactions, both systems also have their potential caveats and are, 
accordingly, better suited to different purposes. Nevertheless, these systems 
represent excellent additions to the toolbox for the study of peroxisome-ER 
contact sites. 
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